BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 013906
(434 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 91.7 bits (226), Expect = 7e-19, Method: Compositional matrix adjust.
Identities = 48/122 (39%), Positives = 76/122 (62%), Gaps = 2/122 (1%)
Query: 308 RRRAKKKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP 367
R++ + + VP E D ++ + + +F ++VA++ FS N LG GGFG+VYKG L
Sbjct: 2 RKKPQDHFFDVPAEE-DPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA 60
Query: 368 SGQEIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNK 426
G +AVKRL QG + +F+ EV +++ HRNL+RL GFC+ E++LVY ++ N
Sbjct: 61 DGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANG 120
Query: 427 SL 428
S+
Sbjct: 121 SV 122
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 87.4 bits (215), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 46/112 (41%), Positives = 70/112 (62%), Gaps = 2/112 (1%)
Query: 318 VPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRL 377
VP E D ++ + + +F ++VA++ F N LG GGFG+VYKG L G +AVKRL
Sbjct: 4 VPAEE-DPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRL 62
Query: 378 SASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
QG + +F+ EV +++ HRNL+RL GFC+ E++LVY ++ N S+
Sbjct: 63 KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV 114
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 77.8 bits (190), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 47/122 (38%), Positives = 73/122 (59%)
Query: 313 KKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI 372
K N++ + + + L ES + +E ATN F +G G FG+VYKGVL G ++
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 373 AVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
A+KR + S QG +EF+ E+ ++ +H +LV L+GFC E E IL+Y+++ N +L L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 433 YG 434
YG
Sbjct: 127 YG 128
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 47/122 (38%), Positives = 73/122 (59%)
Query: 313 KKYNAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI 372
K N++ + + + L ES + +E ATN F +G G FG+VYKGVL G ++
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 373 AVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
A+KR + S QG +EF+ E+ ++ +H +LV L+GFC E E IL+Y+++ N +L L
Sbjct: 67 ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL 126
Query: 433 YG 434
YG
Sbjct: 127 YG 128
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 44/104 (42%), Positives = 64/104 (61%), Gaps = 11/104 (10%)
Query: 335 FDFETIEVATNKFST------DNKLGEGGFGEVYKGVLPSGQEIAVKRLSA----SSGQG 384
F F ++ TN F NK+GEGGFG VYKG + + +AVK+L+A ++ +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 385 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
Q+F E+ ++AK QH NLV LLGF +G++ LVY ++PN SL
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 75.5 bits (184), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 44/104 (42%), Positives = 64/104 (61%), Gaps = 11/104 (10%)
Query: 335 FDFETIEVATNKFST------DNKLGEGGFGEVYKGVLPSGQEIAVKRLSA----SSGQG 384
F F ++ TN F NK+GEGGFG VYKG + + +AVK+L+A ++ +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 385 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
Q+F E+ ++AK QH NLV LLGF +G++ LVY ++PN SL
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 75.1 bits (183), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 44/104 (42%), Positives = 64/104 (61%), Gaps = 11/104 (10%)
Query: 335 FDFETIEVATNKFST------DNKLGEGGFGEVYKGVLPSGQEIAVKRLSA----SSGQG 384
F F ++ TN F NK+GEGGFG VYKG + + +AVK+L+A ++ +
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 385 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
Q+F E+ ++AK QH NLV LLGF +G++ LVY ++PN SL
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 111
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 72.0 bits (175), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 44/104 (42%), Positives = 61/104 (58%), Gaps = 11/104 (10%)
Query: 335 FDFETIEVATNKFST------DNKLGEGGFGEVYKGVLPSGQEIAVKRLSA----SSGQG 384
F F ++ TN F NK GEGGFG VYKG + + +AVK+L+A ++ +
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 385 AQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
Q+F E+ + AK QH NLV LLGF +G++ LVY + PN SL
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSL 108
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 32/87 (36%), Positives = 52/87 (59%), Gaps = 6/87 (6%)
Query: 352 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
+LGEG FG+V+ +LP + +AVK L +S Q+F+ E L+ LQH+++VR
Sbjct: 25 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL 432
G C EG ++V+E++ + L+ FL
Sbjct: 85 FFGVCTEGRPLLMVFEYMRHGDLNRFL 111
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 32/87 (36%), Positives = 52/87 (59%), Gaps = 6/87 (6%)
Query: 352 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
+LGEG FG+V+ +LP + +AVK L +S Q+F+ E L+ LQH+++VR
Sbjct: 19 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL 432
G C EG ++V+E++ + L+ FL
Sbjct: 79 FFGVCTEGRPLLMVFEYMRHGDLNRFL 105
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 32/87 (36%), Positives = 52/87 (59%), Gaps = 6/87 (6%)
Query: 352 KLGEGGFGEVY----KGVLPSGQE--IAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
+LGEG FG+V+ +LP + +AVK L +S Q+F+ E L+ LQH+++VR
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL 432
G C EG ++V+E++ + L+ FL
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFL 134
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 58.2 bits (139), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 6/98 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQEI--AVKRLSASSGQGAQEFKNEVVL 394
+ + +LGEG FG+V+ + P +I AVK L +S ++F E L
Sbjct: 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 68
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LQH ++V+ G C+EG+ I+V+E++ + L+ FL
Sbjct: 69 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFL 106
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 33/87 (37%), Positives = 54/87 (62%), Gaps = 7/87 (8%)
Query: 353 LGEGGFGEVYKGV-LPSGQ----EIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRL 406
LG G FG VYKG+ +P G+ +A+K L+ ++G A EF +E +++A + H +LVRL
Sbjct: 46 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLY 433
LG CL + LV + +P+ L +++
Sbjct: 106 LGVCLSPTIQ-LVTQLMPHGCLLEYVH 131
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 33/87 (37%), Positives = 54/87 (62%), Gaps = 7/87 (8%)
Query: 353 LGEGGFGEVYKGV-LPSGQ----EIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRL 406
LG G FG VYKG+ +P G+ +A+K L+ ++G A EF +E +++A + H +LVRL
Sbjct: 23 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFLY 433
LG CL + LV + +P+ L +++
Sbjct: 83 LGVCLSPTIQ-LVTQLMPHGCLLEYVH 108
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 27 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++KL H+N+VR +G L+ + ++ E + L FL
Sbjct: 87 IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 125
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 56.2 bits (134), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 41 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++KL H+N+VR +G L+ + ++ E + L FL
Sbjct: 101 IISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 139
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 54.7 bits (130), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 27 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 87 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 125
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 41 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 100
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL 139
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 27 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 86
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 87 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 125
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 33 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 92
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 93 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 131
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL 124
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLS-ASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 18 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 77
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 78 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 116
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 43 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 102
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 103 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 141
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 165
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 124
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 53 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 112
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 113 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 151
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 44 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 103
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 104 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 142
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 53.9 bits (128), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRL-SASSGQGAQEFKNEVV 393
EV + LG G FGEVY+G + PS ++AVK L S Q +F E +
Sbjct: 41 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEAL 100
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+++K H+N+VR +G L+ + ++ E + L FL
Sbjct: 101 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL 139
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 12 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E++ N SLD FL
Sbjct: 72 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 108
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 29 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 88
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E++ N SLD FL
Sbjct: 89 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 125
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 39 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 98
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E++ N SLD FL
Sbjct: 99 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 135
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E++ N SLD FL
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E++ N SLD FL
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E++ N SLD FL
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E++ N SLD FL
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E++ N SLD FL
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 52.4 bits (124), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E++ N SLD FL
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 52.4 bits (124), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E++ N SLD FL
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL 137
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 9 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 67
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 105
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 31/100 (31%), Positives = 56/100 (56%), Gaps = 6/100 (6%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVLP--SGQE---IAVKRLSASSGQGAQ-EFKNEV 392
T E+ + + +G G FGEVYKG+L SG++ +A+K L A + + +F E
Sbjct: 38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 97
Query: 393 VLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + H N++RL G + + +++ E++ N +LD FL
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 51.6 bits (122), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYK----GVLPSGQ--EIAVKRLSASSGQGAQ-EFKNEVV 393
E N +GEG FG V++ G+LP +AVK L + Q +F+ E
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
L+A+ + N+V+LLG C G+ L++E++ L+ FL
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 141
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 51.6 bits (122), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 28/87 (32%), Positives = 51/87 (58%), Gaps = 6/87 (6%)
Query: 352 KLGEGGFGEVYKG----VLPSGQE--IAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
+LGEG FG+V+ + P+ + +AVK L + ++F+ E L+ LQH ++V+
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 406 LLGFCLEGEEKILVYEFVPNKSLDYFL 432
G C +G+ I+V+E++ + L+ FL
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFL 108
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 51.6 bits (122), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 331 ESLQFD-FETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEF 388
E+L F + E+ + +KLG G +GEVY GV +AVK L + + +EF
Sbjct: 17 ENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEF 75
Query: 389 KNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
E ++ +++H NLV+LLG C +V E++P LDY
Sbjct: 76 LKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYL 119
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 9 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 67
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 105
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 10/91 (10%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA-------QEFKNEVV 393
+A N+ + ++G+GGFG V+KG L + + A+K L +G QEF+ EV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424
+++ L H N+V+L G L +V EFVP
Sbjct: 76 IMSNLNHPNIVKLYG--LMHNPPRMVMEFVP 104
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSG----QEIAVKRL-SASSGQGAQEFKNEVV 393
E++ + +LGE FG+VYKG L P+ Q +A+K L + G +EF++E +
Sbjct: 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 81
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
L A+LQH N+V LLG + + +++ + + L FL
Sbjct: 82 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL 120
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 104
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 9 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 67
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 105
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 10/91 (10%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA-------QEFKNEVV 393
+A N+ + ++G+GGFG V+KG L + + A+K L +G QEF+ EV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424
+++ L H N+V+L G L +V EFVP
Sbjct: 76 IMSNLNHPNIVKLYG--LMHNPPRMVMEFVP 104
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSG----QEIAVKRL-SASSGQGAQEFKNEVV 393
E++ + +LGE FG+VYKG L P+ Q +A+K L + G +EF++E +
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
L A+LQH N+V LLG + + +++ + + L FL
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFL 103
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 269
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 100
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 10/91 (10%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA-------QEFKNEVV 393
+A N+ + ++G+GGFG V+KG L + + A+K L +G QEF+ EV
Sbjct: 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424
+++ L H N+V+L G L +V EFVP
Sbjct: 76 IMSNLNHPNIVKLYG--LMHNPPRMVMEFVP 104
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 100
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 51.2 bits (121), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 5 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 63
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 64 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 101
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 6 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 64
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 65 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 102
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 250 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 308
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 346
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 5 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 63
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 64 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 101
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 9 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 67
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 105
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 6 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 64
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 65 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 102
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 12 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 71
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E + N SLD FL
Sbjct: 72 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 108
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 9 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 67
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 68 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 105
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 208 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 266
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 267 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 304
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 6 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 64
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 65 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 102
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 52/98 (53%), Gaps = 3/98 (3%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVL 394
+++ E+ + +KLG G +GEVY+GV +AVK L + + +EF E +
Sbjct: 17 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 75
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
+ +++H NLV+LLG C ++ EF+ LDY
Sbjct: 76 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 113
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 50.8 bits (120), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E + N SLD FL
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ S D +G G FGEV G LPS +EI+V + G + ++F E ++
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++RL G + + ++V E + N SLD FL
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL 137
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ 399
E+ + +KLG G FGEVY+GV +AVK L + + +EF E ++ +++
Sbjct: 7 EMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 65
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
H NLV+LLG C ++ EF+ LDY
Sbjct: 66 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 98
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ 399
E+ + +KLG G +GEVY+GV +AVK L + + +EF E ++ +++
Sbjct: 7 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 65
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
H NLV+LLG C ++ EF+ LDY
Sbjct: 66 HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYL 98
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 50.1 bits (118), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 49/88 (55%), Gaps = 8/88 (9%)
Query: 353 LGEGGFGEVYKGVLPS----GQ----EIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
LG+G F +++KGV GQ E+ +K L + ++ F +++KL H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
G C+ G+E ILV EFV SLD +L
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYL 103
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 43/92 (46%), Gaps = 1/92 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ KLG G FGEV+ G + ++AVK L + Q F E L+ LQH
Sbjct: 8 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQH 66
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
LVRL + E ++ EF+ SL FL
Sbjct: 67 DKLVRLYAVVTKEEPIYIITEFMAKGSLLDFL 98
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 8/88 (9%)
Query: 353 LGEGGFGEVYKGVLPS----GQ----EIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
LG+G F +++KGV GQ E+ +K L + ++ F +++KL H++LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
G C G+E ILV EFV SLD +L
Sbjct: 76 LNYGVCFCGDENILVQEFVKFGSLDTYL 103
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 3/93 (3%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ 399
E+ + +KLG G +GEVY+GV +AVK L + + +EF E ++ +++
Sbjct: 7 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIK 65
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP-NKSLDYF 431
H NLV+LLG C ++ EF+ LDY
Sbjct: 66 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 98
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 31/98 (31%), Positives = 45/98 (45%), Gaps = 1/98 (1%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVL 394
+D + E+ +LG G FGEV+ G + ++AVK L + Q F E L
Sbjct: 3 WDKDAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANL 61
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LQH LVRL E ++ E++ SL FL
Sbjct: 62 MKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFL 99
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 45/88 (51%), Gaps = 6/88 (6%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVK--RLSASSGQG 384
E LQ E + + N LGEG FG V +G L + ++AVK +L SS +
Sbjct: 20 EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE 79
Query: 385 AQEFKNEVVLVAKLQHRNLVRLLGFCLE 412
+EF +E + H N++RLLG C+E
Sbjct: 80 IEEFLSEAACMKDFSHPNVIRLLGVCIE 107
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSAS-SGQGAQEFKNEVV 393
T E+ ++ + +G G GEV G L P +++ A+K L A + + ++F +E
Sbjct: 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + H N++RL G G ++V E++ N SLD FL
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSAS-SGQGAQEFKNEVV 393
T E+ ++ + +G G GEV G L P +++ A+K L A + + ++F +E
Sbjct: 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + H N++RL G G ++V E++ N SLD FL
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 24 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 83
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
N++ +G+ + + I V ++ SL + L+
Sbjct: 84 VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH 115
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ A+S + EF NE
Sbjct: 11 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + ++VRLLG +G+ +++ E + L +L
Sbjct: 71 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 109
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 6 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 65
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
N++ +G+ + + I V ++ SL + L+
Sbjct: 66 VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH 97
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 9 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 68
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
N++ +G+ + + I V ++ SL + L+
Sbjct: 69 VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH 100
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ A+S + EF NE
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + ++VRLLG +G+ +++ E + L +L
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 31/99 (31%), Positives = 47/99 (47%), Gaps = 5/99 (5%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS----GQGAQEFKNEVVLV 395
+E+ + + + +G GGFG+VY+ G E+AVK Q + + E L
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYG 434
A L+H N++ L G CL+ LV EF L+ L G
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG 99
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 9 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 68
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
N++ +G+ + + I V ++ SL + L+
Sbjct: 69 VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH 100
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 31 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 90
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
N++ +G+ + + I V ++ SL + L+
Sbjct: 91 VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH 122
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 49/94 (52%), Gaps = 1/94 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 8 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYG 434
N++ +G+ + + I V ++ SL + L+
Sbjct: 68 VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLHA 100
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ A+S + EF NE
Sbjct: 12 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + ++VRLLG +G+ +++ E + L +L
Sbjct: 72 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 110
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ A+S + EF NE
Sbjct: 14 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + ++VRLLG +G+ +++ E + L +L
Sbjct: 74 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 112
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ A+S + EF NE
Sbjct: 15 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + ++VRLLG +G+ +++ E + L +L
Sbjct: 75 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 113
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
N++ +G+ + + I V ++ SL + L+
Sbjct: 64 VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH 95
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ A+S + EF NE
Sbjct: 14 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + ++VRLLG +G+ +++ E + L +L
Sbjct: 74 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 112
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ A+S + EF NE
Sbjct: 8 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + ++VRLLG +G+ +++ E + L +L
Sbjct: 68 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 106
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 32 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 91
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
N++ +G+ + + I V ++ SL + L+
Sbjct: 92 VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH 123
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ A+S + EF NE
Sbjct: 15 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + ++VRLLG +G+ +++ E + L +L
Sbjct: 75 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 113
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ A+S + EF NE
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + ++VRLLG +G+ +++ E + L +L
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQE--IAVKRLSAS-SGQGAQEFKNEVVLV 395
E+ + + +G G FGEV +G L P +E +A+K L + + +EF +E ++
Sbjct: 10 EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIM 69
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ +H N++RL G +++ EF+ N +LD FL
Sbjct: 70 GQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL 106
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
N++ +G+ + + I V ++ SL + L+
Sbjct: 64 VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH 95
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ A+S + EF NE
Sbjct: 8 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + ++VRLLG +G+ +++ E + L +L
Sbjct: 68 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 106
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 32 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 91
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
N++ +G+ + + I V ++ SL + L+
Sbjct: 92 VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH 123
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ A+S + EF NE
Sbjct: 43 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 102
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + ++VRLLG +G+ +++ E + L +L
Sbjct: 103 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 141
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY----KGVLPSGQE--IAVKRLS-ASSGQGAQEFKNEVV 393
EVA K + +LG+G FG VY KGV+ E +A+K ++ A+S + EF NE
Sbjct: 6 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ + ++VRLLG +G+ +++ E + L +L
Sbjct: 66 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 104
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 20 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
N++ +G+ + + I V ++ SL + L+
Sbjct: 80 VNILLFMGYSTKPQLAI-VTQWCEGSSLYHHLH 111
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQE--IAVKRLSAS-SGQGAQEFKNEVVLV 395
E+ + + +G G FGEV +G L P +E +A+K L + + +EF +E ++
Sbjct: 12 EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIM 71
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ +H N++RL G +++ EF+ N +LD FL
Sbjct: 72 GQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL 108
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 47.4 bits (111), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 20 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ EF+P SL +L
Sbjct: 80 KGVCYSAGRRNLKLIMEFLPYGSLREYL 107
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 26/93 (27%), Positives = 48/93 (51%), Gaps = 1/93 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
N++ +G+ + I V ++ SL + L+
Sbjct: 64 VNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH 95
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 27/82 (32%), Positives = 43/82 (52%), Gaps = 1/82 (1%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
++G G FG V+ G + ++A+K + S +F E ++ KL H LV+L G C
Sbjct: 33 QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 411 LEGEEKILVYEFVPNKSLDYFL 432
LE LV+EF+ + L +L
Sbjct: 92 LEQAPICLVFEFMEHGCLSDYL 113
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 1/82 (1%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
++G G FG V+ G + ++A+K + + ++F E ++ KL H LV+L G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 411 LEGEEKILVYEFVPNKSLDYFL 432
LE LV+EF+ + L +L
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYL 91
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 1/82 (1%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
++G G FG V+ G + ++A+K + + ++F E ++ KL H LV+L G C
Sbjct: 16 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 411 LEGEEKILVYEFVPNKSLDYFL 432
LE LV+EF+ + L +L
Sbjct: 75 LEQAPICLVFEFMEHGCLSDYL 96
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 1/82 (1%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
++G G FG V+ G + ++A+K + + ++F E ++ KL H LV+L G C
Sbjct: 13 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 411 LEGEEKILVYEFVPNKSLDYFL 432
LE LV+EF+ + L +L
Sbjct: 72 LEQAPICLVFEFMEHGCLSDYL 93
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 44/82 (53%), Gaps = 1/82 (1%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
++G G FG V+ G + ++A+K + + ++F E ++ KL H LV+L G C
Sbjct: 13 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 411 LEGEEKILVYEFVPNKSLDYFL 432
LE LV+EF+ + L +L
Sbjct: 72 LEQAPICLVFEFMEHGCLSDYL 93
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPS--GQEI--AVKRLSAS-SGQGAQEFKNEVVLVA 396
+A + LGEG FGEVY+GV + G++I AVK + ++F +E V++
Sbjct: 5 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 64
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
L H ++V+L+G +E E ++ E P L ++L
Sbjct: 65 NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL 99
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 1/94 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + + ++G G FG VYKG + + ++A + Q Q FKNEV ++ K +H
Sbjct: 20 EIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYG 434
N++ +G+ + I V ++ SL + L+
Sbjct: 80 VNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHA 112
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPS--GQEI--AVKRLSAS-SGQGAQEFKNEVVLVA 396
+A + LGEG FGEVY+GV + G++I AVK + ++F +E V++
Sbjct: 21 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
L H ++V+L+G +E E ++ E P L ++L
Sbjct: 81 NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL 115
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 6/96 (6%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGVLPS--GQEI--AVKRLSAS-SGQGAQEFKNEVVLVA 396
+A + LGEG FGEVY+GV + G++I AVK + ++F +E V++
Sbjct: 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
L H ++V+L+G +E E ++ E P L ++L
Sbjct: 69 NLDHPHIVKLIGI-IEEEPTWIIMELYPYGELGHYL 103
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/82 (37%), Positives = 45/82 (54%), Gaps = 7/82 (8%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAV----KRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRL 406
LG G FG V+KGV +P G+ I + K + SG Q Q + ++ + L H ++VRL
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 407 LGFCLEGEEKILVYEFVPNKSL 428
LG C G LV +++P SL
Sbjct: 81 LGLC-PGSSLQLVTQYLPLGSL 101
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/82 (37%), Positives = 45/82 (54%), Gaps = 7/82 (8%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAV----KRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRL 406
LG G FG V+KGV +P G+ I + K + SG Q Q + ++ + L H ++VRL
Sbjct: 39 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 407 LGFCLEGEEKILVYEFVPNKSL 428
LG C G LV +++P SL
Sbjct: 99 LGLC-PGSSLQLVTQYLPLGSL 119
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 238
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 239 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG 271
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 46.6 bits (109), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 238
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 239 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG 271
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/117 (26%), Positives = 56/117 (47%), Gaps = 7/117 (5%)
Query: 323 ADNDLTILESLQF----DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS 378
+D D+ E+L F D + +++ + K+G G FG V++ G ++AVK L
Sbjct: 11 SDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILM 69
Query: 379 ASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
+ EF EV ++ +L+H N+V +G + +V E++ SL L+
Sbjct: 70 EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH 126
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SASSGQGAQEFKNEVVLVAKL 398
+ +++ KLGEG +GEVYK + + + +A+KR+ G + EV L+ +L
Sbjct: 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR-EVSLLKEL 90
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
QHRN++ L L++E+ N Y
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYM 123
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 98
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 15 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 73
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 74 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 104
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 14 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 73 EKLVQL--YAVVSEEPIYIVIEYMSKGSLLDFLKG 105
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 17 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP-NKSLDY 430
+ ++ RLLG CL + L+ + +P LDY
Sbjct: 77 NPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDY 107
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 321
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 322 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG 354
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 14 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 72
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 73 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 103
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 15 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 73
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 74 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 104
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 98
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 14 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 73 EKLVQL--YAVVSEEPIYIVIEYMSKGSLLDFLKG 105
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 5 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 64 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 94
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 11 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 69
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 70 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 100
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 98
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 31/117 (26%), Positives = 56/117 (47%), Gaps = 7/117 (5%)
Query: 323 ADNDLTILESLQF----DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLS 378
+D D+ E+L F D + +++ + K+G G FG V++ G ++AVK L
Sbjct: 11 SDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILM 69
Query: 379 ASS--GQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLY 433
+ EF EV ++ +L+H N+V +G + +V E++ SL L+
Sbjct: 70 EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH 126
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 10 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 68
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 69 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 99
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 17 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 75
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 76 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 106
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 19 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 77
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 78 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 108
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 18 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 76
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 77 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 107
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 46.2 bits (108), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G FGEV+ G ++AVK L S F E L+ +LQH
Sbjct: 4 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 63 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 93
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 4 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 62
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 63 EKLVQL--YAVVSEEPIXIVTEYMSKGSLLDFLKG 95
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 5 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 63
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 64 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG 96
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 3 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 61
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 62 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG 94
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 181 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGN-MSPEAFLQEAQVMKKLRH 239
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 240 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG 272
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 7 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 65
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 66 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG 98
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 20 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 80 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 107
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 238
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 239 EKLVQL--YAVVSEEPIYIVGEYMSKGSLLDFLKG 271
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 14 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 73 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG 105
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 16 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 76 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 103
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 50/89 (56%), Gaps = 7/89 (7%)
Query: 351 NKLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 14 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 73 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG 105
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRL 406
LGEG FG+V +G+++AVK L SG + K E+ ++ L H N+V+
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 407 LGFCLE--GEEKILVYEFVPNKSLDYFL 432
G C E G L+ EF+P+ SL +L
Sbjct: 77 KGICTEDGGNGIKLIMEFLPSGSLKEYL 104
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 20 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP 424
+ ++ RLLG CL + L+ + +P
Sbjct: 80 NPHVCRLLGICLTSTVQ-LIMQLMP 103
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRL 406
LGEG FG+V +G+++AVK L SG + K E+ ++ L H N+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 407 LGFCLE--GEEKILVYEFVPNKSLDYFL 432
G C E G L+ EF+P+ SL +L
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYL 116
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 22 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 82 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 109
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 21 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 81 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 108
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP-NKSLDY 430
+ ++ RLLG CL + L+ + +P LDY
Sbjct: 76 NPHVCRLLGICLTSTVQ-LITQLMPFGXLLDY 106
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 50/89 (56%), Gaps = 7/89 (7%)
Query: 351 NKLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 14 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 406 LLGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 74 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL 102
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 69 DNPHVCRLLGICL 81
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 18 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 78 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 105
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 23 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 83 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 110
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 24 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 84 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 111
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 45.8 bits (107), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 20 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 80 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 107
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/86 (32%), Positives = 49/86 (56%), Gaps = 7/86 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+ ++ RLLG CL + L+ + +P
Sbjct: 78 DNPHVCRLLGICLTSTVQ-LIMQLMP 102
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 104
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 17 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP 424
+ ++ RLLG CL + L+ + +P
Sbjct: 77 NPHVCRLLGICLTSTVQ-LIMQLMP 100
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP 424
+ ++ RLLG CL + L+ + +P
Sbjct: 78 NPHVCRLLGICLTSTVQ-LIMQLMP 101
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP 424
+ ++ RLLG CL + L+ + +P
Sbjct: 76 NPHVCRLLGICLTSTVQ-LIMQLMP 99
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 20 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP 424
+ ++ RLLG CL + L+ + +P
Sbjct: 80 NPHVCRLLGICLTSTVQ-LIMQLMP 103
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEI--AVKRL-SASSGQGAQEFKNEVVLV 395
E+ + + +G G FGEV G LP +EI A+K L S + + ++F +E ++
Sbjct: 3 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 62
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++ L G + +++ EF+ N SLD FL
Sbjct: 63 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL 99
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP 424
+ ++ RLLG CL + L+ + +P
Sbjct: 78 NPHVCRLLGICLTSTVQ-LIMQLMP 101
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 49/85 (57%), Gaps = 7/85 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVP 424
+ ++ RLLG CL + L+ + +P
Sbjct: 78 NPHVCRLLGICLTSTVQ-LIMQLMP 101
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 12 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 72 DNPHVCRLLGICL 84
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 26/72 (36%), Positives = 43/72 (59%), Gaps = 6/72 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 400 HRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 76 NPHVCRLLGICL 87
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 26/72 (36%), Positives = 43/72 (59%), Gaps = 6/72 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 26 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 400 HRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 86 NPHVCRLLGICL 97
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 35 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 95 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 122
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 26/72 (36%), Positives = 43/72 (59%), Gaps = 6/72 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 41 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 400 HRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 101 NPHVCRLLGICL 112
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 75 DNPHVCRLLGICL 87
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 21 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 81 DNPHVCRLLGICL 93
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 14 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 73 EKLVQL--YAVVSEEPIYIVCEYMSKGSLLDFLKG 105
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEI--AVKRL-SASSGQGAQEFKNEVVLV 395
E+ + + +G G FGEV G LP +EI A+K L S + + ++F +E ++
Sbjct: 29 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 88
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++ L G + +++ EF+ N SLD FL
Sbjct: 89 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL 125
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 11 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 69
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 70 EKLVQL--YAVVSEEPIYIVTEYMNKGSLLDFLKG 102
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 78 DNPHVCRLLGICL 90
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 17 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 77 DNPHVCRLLGICL 89
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 78 DNPHVCRLLGICL 90
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 45.4 bits (106), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 18 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 78 DNPHVCRLLGICL 90
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 45.4 bits (106), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 11 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 69
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 70 EKLVQL--YAVVSEEPIYIVTEYMNKGSLLDFLKG 102
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 45.4 bits (106), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 75 DNPHVCRLLGICL 87
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 45.4 bits (106), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 28/88 (31%), Positives = 50/88 (56%), Gaps = 7/88 (7%)
Query: 352 KLGEGGFGEV----YKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
+LG+G FG V Y + +G+ +AVK+L S+ + ++F+ E+ ++ LQH N+V+
Sbjct: 35 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 407 LGFCLEGEEK--ILVYEFVPNKSLDYFL 432
G C + L+ E++P SL +L
Sbjct: 95 KGVCYSAGRRNLKLIMEYLPYGSLRDYL 122
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 45.4 bits (106), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 26/72 (36%), Positives = 43/72 (59%), Gaps = 6/72 (8%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKLQ 399
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 18 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 400 HRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 78 NPHVCRLLGICL 89
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 45.4 bits (106), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 22 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 82 DNPHVCRLLGICL 94
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSAS-SGQGAQEFKNEVVLV 395
E+ + + +G G FGEV G L P +EI A+K L A + + ++F +E ++
Sbjct: 25 EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 84
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++ L G + + +++ E++ N SLD FL
Sbjct: 85 GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL 121
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 26/73 (35%), Positives = 43/73 (58%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 22 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 82 DNPHVCRLLGICL 94
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSAS-SGQGAQEFKNEVVLV 395
E+ + + +G G FGEV G L P +EI A+K L A + + ++F +E ++
Sbjct: 10 EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++ L G + + +++ E++ N SLD FL
Sbjct: 70 GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL 106
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVL--PSGQEI--AVKRLSAS-SGQGAQEFKNEVVLV 395
E+ + + +G G FGEV G L P +EI A+K L A + + ++F +E ++
Sbjct: 4 EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++ L G + + +++ E++ N SLD FL
Sbjct: 64 GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL 100
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 26/82 (31%), Positives = 43/82 (52%), Gaps = 1/82 (1%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
++G G FG V+ G + ++A+K + + ++F E ++ KL H LV+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 411 LEGEEKILVYEFVPNKSLDYFL 432
LE LV EF+ + L +L
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL 94
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 45.1 bits (105), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ K++H
Sbjct: 14 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ SL FL G
Sbjct: 73 EKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKG 105
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 34/85 (40%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSA---SSGQGAQEFKNEVVLVAKLQHRNL 403
KLG+G FG V +G PSG+ +AVK L S + +F EV + L HRNL
Sbjct: 18 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSL 428
+RL G L K +V E P SL
Sbjct: 78 IRLYGVVLTPPMK-MVTELAPLGSL 101
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 44.7 bits (104), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 14 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ L FL G
Sbjct: 73 EKLVQL--YAVVSEEPIYIVMEYMSKGCLLDFLKG 105
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 34/85 (40%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSA---SSGQGAQEFKNEVVLVAKLQHRNL 403
KLG+G FG V +G PSG+ +AVK L S + +F EV + L HRNL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSL 428
+RL G L K +V E P SL
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSL 97
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQE--IAVKRLSAS-SGQGAQEFKNEVVLV 395
E+ + + + +G G FGEV G LP +E +A+K L + + ++F E ++
Sbjct: 18 EIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIM 77
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N++ L G + + ++V E++ N SLD FL
Sbjct: 78 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL 114
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSG---QGAQEFKNEVVLV 395
E+ + + +G G FGEV G LP +++AV + G + ++F E ++
Sbjct: 39 ELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIM 98
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ H N+V L G G+ ++V EF+ N +LD FL
Sbjct: 99 GQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL 135
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 34/85 (40%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSA---SSGQGAQEFKNEVVLVAKLQHRNL 403
KLG+G FG V +G PSG+ +AVK L S + +F EV + L HRNL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSL 428
+RL G L K +V E P SL
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSL 97
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 34/85 (40%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSA---SSGQGAQEFKNEVVLVAKLQHRNL 403
KLG+G FG V +G PSG+ +AVK L S + +F EV + L HRNL
Sbjct: 18 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSL 428
+RL G L K +V E P SL
Sbjct: 78 IRLYGVVLTPPMK-MVTELAPLGSL 101
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 44.3 bits (103), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 34/85 (40%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSA---SSGQGAQEFKNEVVLVAKLQHRNL 403
KLG+G FG V +G PSG+ +AVK L S + +F EV + L HRNL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSL 428
+RL G L K +V E P SL
Sbjct: 74 IRLYGVVLTPPMK-MVTELAPLGSL 97
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 34/85 (40%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSA---SSGQGAQEFKNEVVLVAKLQHRNL 403
KLG+G FG V +G PSG+ +AVK L S + +F EV + L HRNL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSL 428
+RL G L K +V E P SL
Sbjct: 84 IRLYGVVLTPPMK-MVTELAPLGSL 107
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 34/85 (40%), Positives = 43/85 (50%), Gaps = 8/85 (9%)
Query: 351 NKLGEGGFGEVYKGVL--PSGQ--EIAVKRLSA---SSGQGAQEFKNEVVLVAKLQHRNL 403
KLG+G FG V +G PSG+ +AVK L S + +F EV + L HRNL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSL 428
+RL G L K +V E P SL
Sbjct: 84 IRLYGVVLTPPMK-MVTELAPLGSL 107
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + KLG+G FGEV+ G +A+K L + + F E ++ KL+H
Sbjct: 14 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 72
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFLYG 434
LV+L + + EE I +V E++ L FL G
Sbjct: 73 EKLVQL--YAVVSEEPIYIVTEYMSKGCLLDFLKG 105
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 43.9 bits (102), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 2/91 (2%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFK-NEVVLVAKLQH 400
++++F KLG G + VYKG+ +G +A+K + S +G E+ L+ +L+H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
N+VRL + LV+EF+ N Y
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYM 93
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V V SG+ +AVK++ Q + NEVV++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 411 LEGEEKILVYEFVPNKSL 428
L G+E +V EF+ +L
Sbjct: 87 LVGDELWVVMEFLEGGAL 104
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 25/73 (34%), Positives = 42/73 (57%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F LG G FG VYKG+ +P G+++ A+ L A+S + +E +E ++A +
Sbjct: 49 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 109 DNPHVCRLLGICL 121
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 28/105 (26%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 325 NDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQ 383
+D ILE L+ ++ K++ K+G+G G VY + + +GQE+A+++++
Sbjct: 2 SDEEILEKLRI-IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 60
Query: 384 GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
+ NE++++ + ++ N+V L L G+E +V E++ SL
Sbjct: 61 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 105
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V V SG+ +AVK++ Q + NEVV++ QH N+V +
Sbjct: 31 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 411 LEGEEKILVYEFVPNKSL 428
L G+E +V EF+ +L
Sbjct: 91 LVGDELWVVMEFLEGGAL 108
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V V SG+ +AVK++ Q + NEVV++ QH N+V +
Sbjct: 38 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 411 LEGEEKILVYEFVPNKSL 428
L G+E +V EF+ +L
Sbjct: 98 LVGDELWVVMEFLEGGAL 115
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 31/92 (33%), Positives = 43/92 (46%), Gaps = 2/92 (2%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
EV +LG G GEV+ G ++AVK L S F E L+ +LQH
Sbjct: 9 EVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQH 67
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LVRL + E ++ E++ N SL FL
Sbjct: 68 QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL 98
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 48/86 (55%), Gaps = 7/86 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F L G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 22 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+ ++ RLLG CL + L+ + +P
Sbjct: 82 DNPHVCRLLGICLTSTVQ-LIMQLMP 106
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 25/73 (34%), Positives = 42/73 (57%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F L G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 15 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 75 DNPHVCRLLGICL 87
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V V SG+ +AVK++ Q + NEVV++ QH N+V +
Sbjct: 36 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 411 LEGEEKILVYEFVPNKSL 428
L G+E +V EF+ +L
Sbjct: 96 LVGDELWVVMEFLEGGAL 113
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSASSGQGAQ-EFKNEVV 393
EV+ K + +LG+G FG VY+G ++ E +AVK ++ S+ + EF NE
Sbjct: 13 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ ++VRLLG +G+ ++V E + + L +L
Sbjct: 73 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSASSGQGAQ-EFKNEVV 393
EV+ K + +LG+G FG VY+G ++ E +AVK ++ S+ + EF NE
Sbjct: 13 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ ++VRLLG +G+ ++V E + + L +L
Sbjct: 73 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSASSGQGAQ-EFKNEVV 393
EV+ K + +LG+G FG VY+G ++ E +AVK ++ S+ + EF NE
Sbjct: 14 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 73
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ ++VRLLG +G+ ++V E + + L +L
Sbjct: 74 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 112
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 25/73 (34%), Positives = 42/73 (57%), Gaps = 6/73 (8%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEI----AVKRL-SASSGQGAQEFKNEVVLVAKL 398
+F L G FG VYKG+ +P G+++ A+K L A+S + +E +E ++A +
Sbjct: 22 TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 399 QHRNLVRLLGFCL 411
+ ++ RLLG CL
Sbjct: 82 DNPHVCRLLGICL 94
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSASSGQGAQ-EFKNEVV 393
EV+ K + +LG+G FG VY+G ++ E +AVK ++ S+ + EF NE
Sbjct: 13 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ ++VRLLG +G+ ++V E + + L +L
Sbjct: 73 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSASSGQGAQ-EFKNEVV 393
EV+ K + +LG+G FG VY+G ++ E +AVK ++ S+ + EF NE
Sbjct: 10 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 69
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ ++VRLLG +G+ ++V E + + L +L
Sbjct: 70 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 108
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSASSGQGAQ-EFKNEVV 393
EV+ K + +LG+G FG VY+G ++ E +AVK ++ S+ + EF NE
Sbjct: 13 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ ++VRLLG +G+ ++V E + + L +L
Sbjct: 73 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSASSGQGAQ-EFKNEVV 393
EV+ K + +LG+G FG VY+G ++ E +AVK ++ S+ + EF NE
Sbjct: 13 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ ++VRLLG +G+ ++V E + + L +L
Sbjct: 73 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 111
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 7/99 (7%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG----VLPSGQE--IAVKRLSASSGQGAQ-EFKNEVV 393
EV+ K + +LG+G FG VY+G ++ E +AVK ++ S+ + EF NE
Sbjct: 12 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 394 LVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ ++VRLLG +G+ ++V E + + L +L
Sbjct: 72 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYL 110
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 28/105 (26%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 325 NDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQ 383
+D ILE L+ ++ K++ K+G+G G VY + + +GQE+A+++++
Sbjct: 1 SDEEILEKLR-SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 384 GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
+ NE++++ + ++ N+V L L G+E +V E++ SL
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V V SG+ +AVK++ Q + NEVV++ QH N+V +
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 411 LEGEEKILVYEFVPNKSL 428
L G+E +V EF+ +L
Sbjct: 218 LVGDELWVVMEFLEGGAL 235
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 42.7 bits (99), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 28/105 (26%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 325 NDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQ 383
+D ILE L+ ++ K++ K+G+G G VY + + +GQE+A+++++
Sbjct: 1 SDEEILEKLR-SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 384 GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
+ NE++++ + ++ N+V L L G+E +V E++ SL
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/105 (26%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 325 NDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQ 383
+D ILE L+ ++ K++ K+G+G G VY + + +GQE+A+++++
Sbjct: 1 SDEEILEKLR-SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 59
Query: 384 GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
+ NE++++ + ++ N+V L L G+E +V E++ SL
Sbjct: 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKNE 391
L++D+E E LG+G +G VY G S Q IA+K + + +Q E
Sbjct: 15 LEYDYEYDENGDRVV-----LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE 69
Query: 392 VVLVAKLQHRNLVRLLG-FCLEGEEKILVYEFVPNKSLDYFL 432
+ L L+H+N+V+ LG F G KI + E VP SL L
Sbjct: 70 IALHKHLKHKNIVQYLGSFSENGFIKIFM-EQVPGGSLSALL 110
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 29/90 (32%), Positives = 47/90 (52%), Gaps = 4/90 (4%)
Query: 343 ATNKFSTDNK---LGEGGFGEVYK-GVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKL 398
A N F T +K LG G FG+V+K +G ++A K + + +E KNE+ ++ +L
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
H NL++L + +LV E+V L
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/105 (26%), Positives = 58/105 (55%), Gaps = 2/105 (1%)
Query: 325 NDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQ 383
+D ILE L+ ++ K++ K+G+G G VY + + +GQE+A+++++
Sbjct: 2 SDEEILEKLR-SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP 60
Query: 384 GAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
+ NE++++ + ++ N+V L L G+E +V E++ SL
Sbjct: 61 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 105
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 308 RRRAKKKYNA---VPEENADNDLTILESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK 363
+ + K KY + E N T ++ Q + E E N LG G FG+V +
Sbjct: 5 KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 364 G-VLPSGQE-----IAVKRLSASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415
G+E +AVK L +++ +E +E+ +++ L QH N+V LLG C G
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 416 KILVYEF 422
+++ E+
Sbjct: 125 VLVITEY 131
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 29/93 (31%), Positives = 46/93 (49%), Gaps = 4/93 (4%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ +LG G FGEV+ G ++A+K L + + F E ++ KL+H
Sbjct: 5 EIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKH 63
Query: 401 RNLVRLLGFCLEGEEKI-LVYEFVPNKSLDYFL 432
LV+L + + EE I +V E++ SL FL
Sbjct: 64 DKLVQL--YAVVSEEPIYIVTEYMNKGSLLDFL 94
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 308 RRRAKKKYNA---VPEENADNDLTILESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK 363
+ + K KY + E N T ++ Q + E E N LG G FG+V +
Sbjct: 5 KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 364 G-VLPSGQE-----IAVKRLSASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415
G+E +AVK L +++ +E +E+ +++ L QH N+V LLG C G
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 416 KILVYEF 422
+++ E+
Sbjct: 125 VLVITEY 131
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 35/102 (34%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 333 LQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKNE 391
L++D+E E LG+G +G VY G S Q IA+K + + +Q E
Sbjct: 1 LEYDYEYDENGDRVV-----LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEE 55
Query: 392 VVLVAKLQHRNLVRLLG-FCLEGEEKILVYEFVPNKSLDYFL 432
+ L L+H+N+V+ LG F G KI + E VP SL L
Sbjct: 56 IALHKHLKHKNIVQYLGSFSENGFIKIFM-EQVPGGSLSALL 96
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 42.4 bits (98), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V V SG+ +AVK++ Q + NEVV++ QH N+V +
Sbjct: 81 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 411 LEGEEKILVYEFVPNKSL 428
L G+E +V EF+ +L
Sbjct: 141 LVGDELWVVMEFLEGGAL 158
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 42.4 bits (98), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 308 RRRAKKKYNA---VPEENADNDLTILESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK 363
+ + K KY + E N T ++ Q + E E N LG G FG+V +
Sbjct: 5 KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 364 G-VLPSGQE-----IAVKRLSASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415
G+E +AVK L +++ +E +E+ +++ L QH N+V LLG C G
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 416 KILVYEF 422
+++ E+
Sbjct: 125 VLVITEY 131
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 42.0 bits (97), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 18/70 (25%), Positives = 37/70 (52%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ ++ ++G G FG VYKG + + ++ + + Q F+NEV ++ K +H
Sbjct: 32 EIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRH 91
Query: 401 RNLVRLLGFC 410
N++ +G+
Sbjct: 92 VNILLFMGYM 101
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 35/127 (27%), Positives = 59/127 (46%), Gaps = 12/127 (9%)
Query: 308 RRRAKKKYNA---VPEENADNDLTILESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYK 363
+ + K KY + E N T ++ Q + E E N LG G FG+V +
Sbjct: 5 KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVE 64
Query: 364 G-VLPSGQE-----IAVKRLSASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEE 415
G+E +AVK L +++ +E +E+ +++ L QH N+V LLG C G
Sbjct: 65 ATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124
Query: 416 KILVYEF 422
+++ E+
Sbjct: 125 VLVITEY 131
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSG---QEIAVKRLSA-SSGQGAQEFKNEVVLVAKL-Q 399
N + +GEG FG+V K + + A+KR+ +S ++F E+ ++ KL
Sbjct: 15 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 74
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ LLG C L E+ P+ +L FL
Sbjct: 75 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 107
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 2/98 (2%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVL 394
++ + E+ + KLG G FGEV+ ++AVK + S + F E +
Sbjct: 172 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANV 230
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LQH LV+L + E ++ EF+ SL FL
Sbjct: 231 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL 267
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 41.6 bits (96), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 2/98 (2%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVL 394
++ + E+ + KLG G FGEV+ ++AVK + S + F E +
Sbjct: 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANV 236
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LQH LV+L + E ++ EF+ SL FL
Sbjct: 237 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL 273
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSG---QEIAVKRLSA-SSGQGAQEFKNEVVLVAKL-Q 399
N + +GEG FG+V K + + A+KR+ +S ++F E+ ++ KL
Sbjct: 22 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 81
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ LLG C L E+ P+ +L FL
Sbjct: 82 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 114
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 5/93 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSG---QEIAVKRLSA-SSGQGAQEFKNEVVLVAKL-Q 399
N + +GEG FG+V K + + A+KR+ +S ++F E+ ++ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ LLG C L E+ P+ +L FL
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL 117
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 2/98 (2%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVL 394
++ + E+ + KLG G FGEV+ ++AVK + S + F E +
Sbjct: 5 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANV 63
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ LQH LV+L + E ++ EF+ SL FL
Sbjct: 64 MKTLQHDKLVKLHA-VVTKEPIYIITEFMAKGSLLDFL 100
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 49/86 (56%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K +VY N LDY
Sbjct: 78 LRYFFYSSGEKKDVVYL---NLVLDY 100
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 35/118 (29%), Positives = 60/118 (50%), Gaps = 10/118 (8%)
Query: 314 KYNAVPEENADNDLTILES-LQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPS 368
++ V E N +N + I + L +D + E N+ S LG G FG+V + G++ S
Sbjct: 8 QWKVVEEINGNNXVXIDPTQLPYDHKW-EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKS 66
Query: 369 --GQEIAVKRLSASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEF 422
+AVK L S+ +E +E+ +++ L H N+V LLG C G +++ E+
Sbjct: 67 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 124
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 35/123 (28%), Positives = 57/123 (46%), Gaps = 12/123 (9%)
Query: 312 KKKYNA---VPEENADNDLTILESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYKG-VL 366
K KY + E N T ++ Q + E E N LG G FG+V +
Sbjct: 1 KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAF 60
Query: 367 PSGQE-----IAVKRLSASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILV 419
G+E +AVK L +++ +E +E+ +++ L QH N+V LLG C G +++
Sbjct: 61 GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 120
Query: 420 YEF 422
E+
Sbjct: 121 TEY 123
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 40.8 bits (94), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKR-LSASSGQGAQEFK-NEVVLVAKLQ 399
+ K+ +GEG +G V K +G+ +A+K+ L + + ++ E+ L+ +L+
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR 82
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
H NLV LL C + + LV+EFV + LD
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDHTILD 112
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/91 (30%), Positives = 45/91 (49%), Gaps = 5/91 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRL---SASSGQGAQEFKNEVVLVAKLQH 400
K+ K+GEG +G V+K EI A+KR+ G + + E+ L+ +L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKH 60
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
+N+VRL ++ LV+EF YF
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF 91
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRL 406
LGEG FG+V +G+ +AVK L A G Q +K E+ ++ L H ++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 407 LGFCLEGEEKI--LVYEFVPNKSLDYFL 432
G C + EK LV E+VP SL +L
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYL 109
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 31/88 (35%), Positives = 46/88 (52%), Gaps = 8/88 (9%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRL 406
LGEG FG+V +G+ +AVK L A G Q +K E+ ++ L H ++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 407 LGFCLEGEEKI--LVYEFVPNKSLDYFL 432
G C + EK LV E+VP SL +L
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYL 109
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 9/114 (7%)
Query: 318 VPEENADNDLTILESLQFDF-ETIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQE---- 371
+ E N T ++ Q + E E N LG G FG+V + G+E
Sbjct: 3 IIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVL 62
Query: 372 -IAVKRLSASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEF 422
+AVK L +++ +E +E+ +++ L QH N+V LLG C G +++ E+
Sbjct: 63 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 116
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRL---SASSGQGAQEFKNEVVLVAKLQHR 401
K+ K+GEG +G V+K EI A+KR+ G + + E+ L+ +L+H+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 61
Query: 402 NLVRLLGFCLEGEEKILVYEFVPNKSLDYF 431
N+VRL ++ LV+EF YF
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF 91
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 9/114 (7%)
Query: 318 VPEENADNDLTILESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYK----GVLPS--GQ 370
V EE N+ ++ Q ++ E N+ S LG G FG+V + G++ S
Sbjct: 18 VVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM 77
Query: 371 EIAVKRLSASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEF 422
+AVK L S+ +E +E+ +++ L H N+V LLG C G +++ E+
Sbjct: 78 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 131
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 9/114 (7%)
Query: 318 VPEENADNDLTILESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYK----GVLPS--GQ 370
V EE N+ ++ Q ++ E N+ S LG G FG+V + G++ S
Sbjct: 18 VVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM 77
Query: 371 EIAVKRLSASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEF 422
+AVK L S+ +E +E+ +++ L H N+V LLG C G +++ E+
Sbjct: 78 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 131
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 33/114 (28%), Positives = 56/114 (49%), Gaps = 9/114 (7%)
Query: 318 VPEENADNDLTILESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYK----GVLPS--GQ 370
V EE N+ ++ Q ++ E N+ S LG G FG+V + G++ S
Sbjct: 13 VVEEINGNNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAM 72
Query: 371 EIAVKRLSASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEF 422
+AVK L S+ +E +E+ +++ L H N+V LLG C G +++ E+
Sbjct: 73 TVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 126
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 51 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 105
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 106 LRYFFYSSGEKKDEVYL---NLVLDY 128
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/86 (43%), Positives = 50/86 (58%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ QG + FKN E+ ++ KL H N+VR
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 78 LRYFFYSSGEKKDEVYL---NLVLDY 100
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 111
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 112 LRYFFYSSGEKKDEVYL---NLVLDY 134
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 59 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 113
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 114 LRYFFYSSGEKKDEVYL---NLVLDY 136
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 40.0 bits (92), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/86 (43%), Positives = 50/86 (58%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ QG + FKN E+ ++ KL H N+VR
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 78 LRYFFYSSGEKKDEVYL---NLVLDY 100
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 61 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 115
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 116 LRYFFYSSGEKKDEVYL---NLVLDY 138
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 57 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 111
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 112 LRYFFYSSGEKKDEVYL---NLVLDY 134
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 102 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 156
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 157 LRYFFYSSGEKKDEVYL---NLVLDY 179
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 28 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 82
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 83 LRYFFYSSGEKKDEVYL---NLVLDY 105
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/86 (43%), Positives = 50/86 (58%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ QG + FKN E+ ++ KL H N+VR
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QG-KAFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 78 LRYFFYSSGEKKDEVYL---NLVLDY 100
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 36 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 90
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 91 LRYFFYSSGEKKDEVYL---NLVLDY 113
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFG--EVYKGVLPSGQEIAVKRLSASSGQGAQEF 388
E+L F + + + KLGEGGF ++ +G L G A+KR+ Q +E
Sbjct: 15 ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEA 73
Query: 389 KNEVVLVAKLQHRNLVRLLGFCL 411
+ E + H N++RL+ +CL
Sbjct: 74 QREADMHRLFNHPNILRLVAYCL 96
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 42 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 96
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 97 LRYFFYSSGEKKDEVYL---NLVLDY 119
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 35 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 89
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 90 LRYFFYSSGEKKDEVYL---NLVLDY 112
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 31 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 85
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 86 LRYFFYSSGEKKDEVYL---NLVLDY 108
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 39.7 bits (91), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 35 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 89
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 90 LRYFFYSSGEKKDEVYL---NLVLDY 112
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 5/94 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQ---EIAVKRLSASSGQG-AQEFKNEVVLVAKLQH 400
N D +LG G FG V +GV + ++A+K L + + +E E ++ +L +
Sbjct: 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 395
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYG 434
+VRL+G C + E +LV E L FL G
Sbjct: 396 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG 428
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 39/81 (48%), Gaps = 2/81 (2%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRN 402
K+ K+GEG +G VYK G+ +A+K RL A E+ L+ +L H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 403 LVRLLGFCLEGEEKILVYEFV 423
+V L+ LV+EF+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFM 101
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 78 LRYFFYSSGEKKDEVYL---NLVLDY 100
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 78 LRYFFYSSGEKKDEVYL---NLVLDY 100
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 77
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 78 LRYFFYSSGEKKDEVYL---NLVLDY 100
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 24 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 78
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 79 LRYFFYSSGEKKDEVYL---NLVLDY 101
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/86 (40%), Positives = 48/86 (55%), Gaps = 12/86 (13%)
Query: 349 TDNK-LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVR 405
TD K +G G FG VY+ L SG+ +A+K++ + FKN E+ ++ KL H N+VR
Sbjct: 27 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVR 81
Query: 406 LLGFCL-EGEEKILVYEFVPNKSLDY 430
L F GE+K VY N LDY
Sbjct: 82 LRYFFYSSGEKKDEVYL---NLVLDY 104
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 56 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 116 GICLRSEGSPLV 127
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 26/81 (32%), Positives = 39/81 (48%), Gaps = 2/81 (2%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRN 402
K+ K+GEG +G VYK G+ +A+K RL A E+ L+ +L H N
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 403 LVRLLGFCLEGEEKILVYEFV 423
+V L+ LV+EF+
Sbjct: 81 IVSLIDVIHSERCLTLVFEFM 101
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 41/78 (52%), Gaps = 1/78 (1%)
Query: 352 KLGEGGFGEV-YKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V SG+++AVK + Q + NEVV++ QH N+V +
Sbjct: 52 KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 411 LEGEEKILVYEFVPNKSL 428
L GEE ++ EF+ +L
Sbjct: 112 LVGEELWVLMEFLQGGAL 129
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 37 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 97 GICLRSEGSPLV 108
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 36 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 96 GICLRSEGSPLV 107
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 98 GICLRSEGSPLV 109
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 57 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 117 GICLRSEGSPLV 128
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 98 GICLRSEGSPLV 109
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 98 GICLRSEGSPLV 109
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 39.3 bits (90), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 5/103 (4%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFK 389
E ++ D + EV + +LG+G FG+VYK +G A K + S + +++
Sbjct: 1 EHVRRDLDPNEV----WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 56
Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
E+ ++A H +V+LLG + ++ EF P ++D +
Sbjct: 57 VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM 99
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVL 394
D++ IEV + +G G FG V K +++A+K++ + S + A F E+
Sbjct: 6 IDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQ 55
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYG 434
++++ H N+V+L G CL LV E+ SL L+G
Sbjct: 56 LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHG 93
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 43 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 103 GICLRSEGSPLV 114
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 30 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 90 GICLRSEGSPLV 101
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVL--PSGQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 157 GICLRSEGSPLV 168
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 93 GICLRSEGSPLV 104
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 95 GICLRSEGSPLV 106
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 4/90 (4%)
Query: 347 FSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGA---QEFKNEVVLVAKLQHRN 402
F N LG+G F VY+ + +G E+A+K + + A Q +NEV + +L+H +
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++ L + + LV E N ++ +L
Sbjct: 73 ILELYNYFEDSNYVYLVLEMCHNGEMNRYL 102
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/103 (26%), Positives = 51/103 (49%), Gaps = 5/103 (4%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFK 389
E ++ D + EV + +LG+G FG+VYK +G A K + S + +++
Sbjct: 9 EHVRRDLDPNEV----WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYI 64
Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
E+ ++A H +V+LLG + ++ EF P ++D +
Sbjct: 65 VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM 107
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 38 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 98 GICLRSEGSPLV 109
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 39 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 99 GICLRSEGSPLV 110
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 37 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 97 GICLRSEGSPLV 108
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 29/81 (35%), Positives = 47/81 (58%), Gaps = 5/81 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412
+G+G FG+V G G ++AVK + + AQ F E ++ +L+H NLV+LLG +E
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 413 GEEKI-LVYEFVPNKSL-DYF 431
+ + +V E++ SL DY
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL 278
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 39 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 99 GICLRSEGSPLV 110
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 30/100 (30%), Positives = 51/100 (51%), Gaps = 12/100 (12%)
Query: 335 FDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVL 394
D++ IEV + +G G FG V K +++A+K++ + S + A F E+
Sbjct: 5 IDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQ 54
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYG 434
++++ H N+V+L G CL LV E+ SL L+G
Sbjct: 55 LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHG 92
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 40/89 (44%), Gaps = 1/89 (1%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQ 399
+E+ + + +LG G FG V G ++AVK + S EF E + KL
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLS 61
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
H LV+ G C + +V E++ N L
Sbjct: 62 HPKLVKFYGVCSKEYPIYIVTEYISNGCL 90
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 7/78 (8%)
Query: 353 LGEGGFGEVYKGV-LPSGQ----EIAVKRLSA-SSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LG G FG VYKG+ +P G+ +A+K L +S + +E +E ++A + + RL
Sbjct: 25 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 407 LGFCLEGEEKILVYEFVP 424
LG CL + LV + +P
Sbjct: 85 LGICLTSTVQ-LVTQLMP 101
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 27/72 (37%), Positives = 38/72 (52%), Gaps = 5/72 (6%)
Query: 353 LGEGGFGEVYKGVLPS--GQEI--AVKRLSASSGQG-AQEFKNEVVLVAKLQHRNLVRLL 407
+G G FG VY G L G++I AVK L+ + G +F E +++ H N++ LL
Sbjct: 36 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 408 GFCLEGEEKILV 419
G CL E LV
Sbjct: 96 GICLRSEGSPLV 107
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 5/94 (5%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQ---EIAVKRLSASSGQG-AQEFKNEVVLVAKLQH 400
N D +LG G FG V +GV + ++A+K L + + +E E ++ +L +
Sbjct: 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 69
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLYG 434
+VRL+G C + E +LV E L FL G
Sbjct: 70 PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG 102
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 41/92 (44%), Gaps = 1/92 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + +LG G FG V G ++A+K + S EF E ++ L H
Sbjct: 5 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
LV+L G C + ++ E++ N L +L
Sbjct: 64 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 95
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 29/94 (30%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 342 VATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKL 398
V F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L
Sbjct: 4 VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N+V+LL + LV+EF+ ++ L F+
Sbjct: 64 NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM 96
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 1/96 (1%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVA 396
+ + E+ + +LG G FG V G ++A+K + S EF E ++
Sbjct: 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMM 74
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
L H LV+L G C + ++ E++ N L +L
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 110
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 41/92 (44%), Gaps = 1/92 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + +LG G FG V G ++A+K + S EF E ++ L H
Sbjct: 4 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
LV+L G C + ++ E++ N L +L
Sbjct: 63 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 94
>pdb|3A2E|A Chain A, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
pdb|3A2E|B Chain B, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
pdb|3A2E|C Chain C, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
pdb|3A2E|D Chain D, Crystal Structure Of Ginkbilobin-2, The Novel Antifungal
Protein From Ginkgo Biloba Seeds
Length = 108
Score = 38.9 bits (89), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 25/98 (25%), Positives = 38/98 (38%)
Query: 151 NTQNATDPVKFNDLVGSLMGEAASQAVNDPKKFATKMANFTSFQKLYALAQCTQDLSSSD 210
NTQ FN + +++ + + T A Y A C Q +S SD
Sbjct: 11 NTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSD 70
Query: 211 CNICLRGAIAQLPTCCGGKQGGRVLTPSCNVRYEVYPF 248
C CL + ++ + C G RV C ++YE F
Sbjct: 71 CTACLSNLVNRIFSICNNAIGARVQLVDCFIQYEQRSF 108
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 1/96 (1%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVA 396
+ + E+ + +LG G FG V G ++A+K + S EF E ++
Sbjct: 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMM 74
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
L H LV+L G C + ++ E++ N L +L
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 110
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 30/120 (25%), Positives = 54/120 (45%), Gaps = 12/120 (10%)
Query: 325 NDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSAS 380
+ L I + L+ E + + +F+ LG+G FG V + L S ++AVK L A
Sbjct: 3 DSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD 62
Query: 381 --SGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLEGEEK------ILVYEFVPNKSLDYFL 432
+ +EF E + + H ++ +L+G L K +++ F+ + L FL
Sbjct: 63 IIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL 122
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 41/92 (44%), Gaps = 1/92 (1%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQH 400
E+ + +LG G FG V G ++A+K + S EF E ++ L H
Sbjct: 5 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
LV+L G C + ++ E++ N L +L
Sbjct: 64 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 95
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/96 (26%), Positives = 43/96 (44%), Gaps = 1/96 (1%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVA 396
+ + E+ + +LG G FG V G ++A+K + S EF E ++
Sbjct: 7 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMM 65
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
L H LV+L G C + ++ E++ N L +L
Sbjct: 66 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 101
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 9/114 (7%)
Query: 317 AVPEENADNDLTILESLQFDFETI--EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-A 373
+ PE N + +L S Q + E+ + A F LG+G FG VY + I A
Sbjct: 7 SAPENNPEEELA---SKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA 63
Query: 374 VKRLSASSGQGA---QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424
+K L + + A + + EV + + L+H N++RL G+ + L+ E+ P
Sbjct: 64 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 117
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 1/78 (1%)
Query: 352 KLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
K+GEG G V +G+++AVK++ Q + NEVV++ H N+V +
Sbjct: 52 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 411 LEGEEKILVYEFVPNKSL 428
L G+E +V EF+ +L
Sbjct: 112 LVGDELWVVMEFLEGGAL 129
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 38.5 bits (88), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 32/114 (28%), Positives = 54/114 (47%), Gaps = 9/114 (7%)
Query: 317 AVPEENADNDLTILESLQFDFETI--EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-A 373
+ PE N + +L S Q + E+ + A F LG+G FG VY + I A
Sbjct: 7 SAPENNPEEELA---SKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILA 63
Query: 374 VKRLSASSGQGA---QEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVP 424
+K L + + A + + EV + + L+H N++RL G+ + L+ E+ P
Sbjct: 64 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 117
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 1/82 (1%)
Query: 351 NKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFC 410
+LG G FG V G ++A+K + S EF E ++ L H LV+L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 411 LEGEEKILVYEFVPNKSLDYFL 432
+ ++ E++ N L +L
Sbjct: 69 TKQRPIFIITEYMANGCLLNYL 90
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 27/88 (30%), Positives = 43/88 (48%), Gaps = 3/88 (3%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYF 431
V+LL + LV+EF+ D+
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQDLKDFM 92
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 38.5 bits (88), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 29/81 (35%), Positives = 47/81 (58%), Gaps = 5/81 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412
+G+G FG+V G G ++AVK + + AQ F E ++ +L+H NLV+LLG +E
Sbjct: 20 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 413 GEEKI-LVYEFVPNKSL-DYF 431
+ + +V E++ SL DY
Sbjct: 77 EKGGLYIVTEYMAKGSLVDYL 97
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 29/81 (35%), Positives = 47/81 (58%), Gaps = 5/81 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412
+G+G FG+V G G ++AVK + + AQ F E ++ +L+H NLV+LLG +E
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 413 GEEKI-LVYEFVPNKSL-DYF 431
+ + +V E++ SL DY
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYL 106
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 29/81 (35%), Positives = 47/81 (58%), Gaps = 5/81 (6%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCLE 412
+G+G FG+V G G ++AVK + + AQ F E ++ +L+H NLV+LLG +E
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 413 GEEKI-LVYEFVPNKSL-DYF 431
+ + +V E++ SL DY
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYL 91
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 38.1 bits (87), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL---SASSGQGAQEFKNEVVLVAKLQHRN 402
F K+GEG +G VYK +G+ +A+K++ + + G + + E+ L+ +L H N
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 63
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+V+LL + LV+EF+ ++ L F+
Sbjct: 64 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 95
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 94
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 94
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 9/107 (8%)
Query: 325 NDLTILESLQFDFE-TIEVATNKFSTDNKLGEGGFGEVYK----GVLPS--GQEIAVKRL 377
N+ ++ Q ++ E N+ S LG G FG+V + G++ S +AVK L
Sbjct: 2 NNYVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 378 SASSGQGAQE-FKNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEF 422
S+ +E +E+ +++ L H N+V LLG C G +++ E+
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 108
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 26/80 (32%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 404 VRLLGFCLEGEEKILVYEFV 423
V+LL + LV+EF+
Sbjct: 68 VKLLDVIHTENKLYLVFEFL 87
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 38.1 bits (87), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-HQDLKTFM 95
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 38.1 bits (87), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 67 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 94
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 38.1 bits (87), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 68 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 95
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 38.1 bits (87), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 66 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 93
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 72 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 99
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 69 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 96
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 26/80 (32%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 404 VRLLGFCLEGEEKILVYEFV 423
V+LL + LV+EF+
Sbjct: 67 VKLLDVIHTENKLYLVFEFL 86
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 72 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 99
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 26/80 (32%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 404 VRLLGFCLEGEEKILVYEFV 423
V+LL + LV+EF+
Sbjct: 68 VKLLDVIHTENKLYLVFEFL 87
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK-----RLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LGEG FG+V +GQ++A+K L+ S QG E E+ + L+H ++++L
Sbjct: 12 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 69
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFL 432
+E I+V E+ N+ DY +
Sbjct: 70 YDVIKSKDEIIMVIEYAGNELFDYIV 95
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 26/80 (32%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 404 VRLLGFCLEGEEKILVYEFV 423
V+LL + LV+EF+
Sbjct: 66 VKLLDVIHTENKLYLVFEFL 85
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 37.7 bits (86), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK-----RLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LGEG FG+V +GQ++A+K L+ S QG E E+ + L+H ++++L
Sbjct: 21 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 78
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFL 432
+E I+V E+ N+ DY +
Sbjct: 79 YDVIKSKDEIIMVIEYAGNELFDYIV 104
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 37.7 bits (86), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK-----RLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LGEG FG+V +GQ++A+K L+ S QG E E+ + L+H ++++L
Sbjct: 22 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 79
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFL 432
+E I+V E+ N+ DY +
Sbjct: 80 YDVIKSKDEIIMVIEYAGNELFDYIV 105
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 37.7 bits (86), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 45/86 (52%), Gaps = 8/86 (9%)
Query: 353 LGEGGFGEVYKGV-LPSGQEIAVK-----RLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LGEG FG+V +GQ++A+K L+ S QG E E+ + L+H ++++L
Sbjct: 16 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 73
Query: 407 LGFCLEGEEKILVYEFVPNKSLDYFL 432
+E I+V E+ N+ DY +
Sbjct: 74 YDVIKSKDEIIMVIEYAGNELFDYIV 99
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP 91
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 37.4 bits (85), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRL 406
LGEG FG+V +G+ +AVK L A +G Q +K E+ ++ L H ++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 407 LGFCLE-GEEKI-LVYEFVPNKSLDYFL 432
G C + G + LV E+VP SL +L
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL 126
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 37.4 bits (85), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 5 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 65 RHPNILRLYGYFHDATRVYLILEYAP 90
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 37.4 bits (85), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP 91
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 37.4 bits (85), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRL 406
LGEG FG+V +G+ +AVK L G Q ++ E+ ++ L H ++V+
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 407 LGFCL-EGEEKI-LVYEFVPNKSLDYFL 432
G C +GE+ + LV E+VP SL +L
Sbjct: 77 KGCCEDQGEKSVQLVMEYVPLGSLRDYL 104
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 37.4 bits (85), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAP 92
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 37.4 bits (85), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP 94
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 37.4 bits (85), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAP 92
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAP 96
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 353 LGEGGFGEVYKGVLP-----SGQEIAVKRLSASSG-QGAQEFKNEVVLVAKLQHRNLVRL 406
LGEG FG+V +G+ +AVK L G Q ++ E+ ++ L H ++V+
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 407 LGFCL-EGEEKI-LVYEFVPNKSLDYFL 432
G C +GE+ + LV E+VP SL +L
Sbjct: 76 KGCCEDQGEKSVQLVMEYVPLGSLRDYL 103
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP 94
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP 91
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 37.4 bits (85), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP 91
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP 91
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAP 96
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP 94
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP 94
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP 91
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 68 RHPNILRLYGYFHDATRVYLILEYAP 93
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 66 RHPNILRLYGYFHDATRVYLILEYAP 91
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAP 96
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 37.4 bits (85), Expect = 0.018, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 8 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 68 RHPNILRLYGYFHDATRVYLILEYAP 93
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 37.4 bits (85), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 25/84 (29%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 351 NKLGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLG 408
++G G FGEV+ G L + +AVK + + +F E ++ + H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 409 FCLEGEEKILVYEFVPNKSLDYFL 432
C + + +V E V FL
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFL 203
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAP 92
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP 94
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 23/87 (26%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
K+ LG G FG V++ V S ++ + + G K E+ ++ +HRN++
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYF 431
L EE ++++EF+ LD F
Sbjct: 65 HLHESFESMEELVMIFEFISG--LDIF 89
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 25/84 (29%), Positives = 41/84 (48%), Gaps = 2/84 (2%)
Query: 351 NKLGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLG 408
++G G FGEV+ G L + +AVK + + +F E ++ + H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 409 FCLEGEEKILVYEFVPNKSLDYFL 432
C + + +V E V FL
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFL 203
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 10 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 70 RHPNILRLYGYFHDATRVYLILEYAP 95
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 37.0 bits (84), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 42/86 (48%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + + I A+K L + + A + + EV + + L
Sbjct: 6 ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 66 RHPNILRLYGYFHDSTRVYLILEYAP 91
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 37.0 bits (84), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 9 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 69 RHPNILRLYGYFHDATRVYLILEYAP 94
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 37.0 bits (84), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAP 96
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 37.0 bits (84), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 23 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 83 RHPNILRLYGYFHDATRVYLILEYAP 108
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 37.0 bits (84), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 3/88 (3%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQH 400
T+++ +LG+G F V + + +P+GQE A K ++ S + Q+ + E + L+H
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL 428
N+VRL E LV++ V L
Sbjct: 63 PNIVRLHDSISEEGFHYLVFDLVTGGEL 90
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 37.0 bits (84), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 32/113 (28%), Positives = 52/113 (46%), Gaps = 13/113 (11%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVL------PSGQEIAVKRLSASSGQG 384
E L +D E A + LG G FG+V + P+ + +AVK L G
Sbjct: 13 ERLPYDASKWEFARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKML--KEGAT 70
Query: 385 AQEFK---NEVVLVAKL-QHRNLVRLLGFCL-EGEEKILVYEFVPNKSLDYFL 432
A E+K E+ ++ + H N+V LLG C +G +++ E+ +L +L
Sbjct: 71 ASEYKALMTELKILTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYL 123
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 37.0 bits (84), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+E V ++ L F+
Sbjct: 64 VKLLDVIHTENKLYLVFEHV-HQDLKTFM 91
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 37.0 bits (84), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 11 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 71 RHPNILRLYGYFHDATRVYLILEYAP 96
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 37.0 bits (84), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 4/86 (4%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKL 398
A F LG+G FG VY + I A+K L + + A + + EV + + L
Sbjct: 3 ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 399 QHRNLVRLLGFCLEGEEKILVYEFVP 424
+H N++RL G+ + L+ E+ P
Sbjct: 63 RHPNILRLYGYFHDATRVYLILEYAP 88
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 3/88 (3%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQH 400
T+++ +LG+G F V + + +P+GQE A K ++ S + Q+ + E + L+H
Sbjct: 3 TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL 428
N+VRL E LV++ V L
Sbjct: 63 PNIVRLHDSISEEGFHYLVFDLVTGGEL 90
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 36.6 bits (83), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 7/81 (8%)
Query: 334 QFDF--ETIEVATNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN 390
Q DF +T+E+ + L EGGF VY+ + SG+E A+KRL ++ + +
Sbjct: 15 QSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ 74
Query: 391 EVVLVAKLQ-HRNLVRLLGFC 410
EV + KL H N+V+ FC
Sbjct: 75 EVCFMKKLSGHPNIVQ---FC 92
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 36.6 bits (83), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 28/99 (28%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 339 TIEVATNKFSTDN-----KLGEGGFGEVYKGVLPSGQEI-AVKRL--SASSGQGAQ-EFK 389
T ++ T F+ D+ LG+G FG VY I A+K L S +G + + +
Sbjct: 12 TPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLR 71
Query: 390 NEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
E+ + A L H N++RL + + L+ E+ P L
Sbjct: 72 REIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL 110
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 36.6 bits (83), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 28/89 (31%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+K RL + E+ L+ +L H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+E V ++ L F+
Sbjct: 68 VKLLDVIHTENKLYLVFEHV-DQDLKKFM 95
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 36.6 bits (83), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 29/85 (34%), Positives = 44/85 (51%), Gaps = 7/85 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLL----G 408
+G G +G VYKG L + +AVK S ++ Q KN + V ++H N+ R +
Sbjct: 21 IGRGRYGAVYKGSLDE-RPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIARFIVGDER 78
Query: 409 FCLEGE-EKILVYEFVPNKSLDYFL 432
+G E +LV E+ PN SL +L
Sbjct: 79 VTADGRMEYLLVMEYYPNGSLXKYL 103
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 36.6 bits (83), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 40/77 (51%), Gaps = 3/77 (3%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVR 405
F KLGEG +G VYK + +GQ +A+K++ S QE E+ ++ + ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88
Query: 406 LLGFCLEGEEKILVYEF 422
G + + +V E+
Sbjct: 89 YYGSYFKNTDLWIVMEY 105
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 36.6 bits (83), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 43/80 (53%), Gaps = 4/80 (5%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN---EVVLVAKLQHRN 402
FS ++G G FG VY + + + +A+K++S S Q +++++ EV + KL+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 403 LVRLLGFCLEGEEKILVYEF 422
++ G L LV E+
Sbjct: 116 TIQYRGCYLREHTAWLVMEY 135
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 36.6 bits (83), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 24/80 (30%), Positives = 43/80 (53%), Gaps = 4/80 (5%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN---EVVLVAKLQHRN 402
FS ++G G FG VY + + + +A+K++S S Q +++++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 403 LVRLLGFCLEGEEKILVYEF 422
++ G L LV E+
Sbjct: 77 TIQYRGCYLREHTAWLVMEY 96
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 36.2 bits (82), Expect = 0.032, Method: Compositional matrix adjust.
Identities = 20/70 (28%), Positives = 39/70 (55%), Gaps = 3/70 (4%)
Query: 344 TNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQEFK--NEVVLVAKLQH 400
+K+ K+G+G FGEV+K +GQ++A+K++ + + E+ ++ L+H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 401 RNLVRLLGFC 410
N+V L+ C
Sbjct: 77 ENVVNLIEIC 86
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 36.2 bits (82), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 20/70 (28%), Positives = 39/70 (55%), Gaps = 3/70 (4%)
Query: 344 TNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQEFK--NEVVLVAKLQH 400
+K+ K+G+G FGEV+K +GQ++A+K++ + + E+ ++ L+H
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 75
Query: 401 RNLVRLLGFC 410
N+V L+ C
Sbjct: 76 ENVVNLIEIC 85
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 36.2 bits (82), Expect = 0.035, Method: Compositional matrix adjust.
Identities = 20/70 (28%), Positives = 39/70 (55%), Gaps = 3/70 (4%)
Query: 344 TNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQEFK--NEVVLVAKLQH 400
+K+ K+G+G FGEV+K +GQ++A+K++ + + E+ ++ L+H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 401 RNLVRLLGFC 410
N+V L+ C
Sbjct: 77 ENVVNLIEIC 86
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 36.2 bits (82), Expect = 0.037, Method: Compositional matrix adjust.
Identities = 20/70 (28%), Positives = 39/70 (55%), Gaps = 3/70 (4%)
Query: 344 TNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQEFK--NEVVLVAKLQH 400
+K+ K+G+G FGEV+K +GQ++A+K++ + + E+ ++ L+H
Sbjct: 17 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 76
Query: 401 RNLVRLLGFC 410
N+V L+ C
Sbjct: 77 ENVVNLIEIC 86
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 36.2 bits (82), Expect = 0.040, Method: Compositional matrix adjust.
Identities = 23/78 (29%), Positives = 38/78 (48%), Gaps = 3/78 (3%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEI--AVKRLSASSGQGAQEF 388
E+L F T ++ +N +G G +GEV K + G I A K++ + F
Sbjct: 12 ENLYFQGSTKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRF 70
Query: 389 KNEVVLVAKLQHRNLVRL 406
K E+ ++ L H N++RL
Sbjct: 71 KQEIEIMKSLDHPNIIRL 88
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 36.2 bits (82), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 21/82 (25%), Positives = 37/82 (45%), Gaps = 7/82 (8%)
Query: 330 LESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFK 389
L+ FE +E+ +G+G FG+VY G I + + + + FK
Sbjct: 25 LQEWDIPFEQLEIG-------ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFK 77
Query: 390 NEVVLVAKLQHRNLVRLLGFCL 411
EV+ + +H N+V +G C+
Sbjct: 78 REVMAYRQTRHENVVLFMGACM 99
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 36.2 bits (82), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+ RL + E+ L+ +L H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 65 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 92
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 36.2 bits (82), Expect = 0.041, Method: Compositional matrix adjust.
Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 4/89 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
F K+GEG +G VYK +G+ +A+ RL + E+ L+ +L H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
V+LL + LV+EF+ ++ L F+
Sbjct: 64 VKLLDVIHTENKLYLVFEFL-HQDLKKFM 91
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 35.8 bits (81), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 40/82 (48%), Gaps = 4/82 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKLQHRN 402
F LG+G FG VY + I A+K L + + A + + EV + + L+H N
Sbjct: 14 FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 403 LVRLLGFCLEGEEKILVYEFVP 424
++RL G+ + L+ E+ P
Sbjct: 74 ILRLYGYFHDATRVYLILEYAP 95
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 35.8 bits (81), Expect = 0.045, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 40/82 (48%), Gaps = 4/82 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI-AVKRLSASSGQGA---QEFKNEVVLVAKLQHRN 402
F LG+G FG VY + I A+K L + + A + + EV + + L+H N
Sbjct: 14 FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 403 LVRLLGFCLEGEEKILVYEFVP 424
++RL G+ + L+ E+ P
Sbjct: 74 ILRLYGYFHDATRVYLILEYAP 95
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 35.8 bits (81), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 39/80 (48%), Gaps = 2/80 (2%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
K+ K+GEG +G VYK G+ A+K RL E+ ++ +L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 404 VRLLGFCLEGEEKILVYEFV 423
V+L + +LV+E +
Sbjct: 63 VKLYDVIHTKKRLVLVFEHL 82
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 35.8 bits (81), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 19/62 (30%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQEI--AVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
++ +N +G G +GEV K + G I A K++ + FK E+ ++ L H N++
Sbjct: 11 YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 405 RL 406
RL
Sbjct: 70 RL 71
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 35.8 bits (81), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 25/72 (34%), Positives = 35/72 (48%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + A L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 75 REGNIQYLFLEY 86
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 35.8 bits (81), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 39/80 (48%), Gaps = 2/80 (2%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
K+ K+GEG +G VYK G+ A+K RL E+ ++ +L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 404 VRLLGFCLEGEEKILVYEFV 423
V+L + +LV+E +
Sbjct: 63 VKLYDVIHTKKRLVLVFEHL 82
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 35.8 bits (81), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSASSGQGAQE-FKNEVVLV 395
E+ + +GEG FG+V++G+ S + +A+K + +E F E + +
Sbjct: 6 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 396 AKLQHRNLVRLLGFCLEGEEKILV 419
+ H ++V+L+G E I++
Sbjct: 66 RQFDHPHIVKLIGVITENPVWIIM 89
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 35.8 bits (81), Expect = 0.054, Method: Compositional matrix adjust.
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 3/84 (3%)
Query: 351 NKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLG 408
+KLGEG + VYKG + +A+K + +GA EV L+ L+H N+V L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 409 FCLEGEEKILVYEFVPNKSLDYFL 432
+ LV+E++ +K L +L
Sbjct: 68 IIHTEKSLTLVFEYL-DKDLKQYL 90
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 35.4 bits (80), Expect = 0.055, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSASSGQGAQE-FKNEVVLV 395
E+ + +GEG FG+V++G+ S + +A+K + +E F E + +
Sbjct: 6 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 396 AKLQHRNLVRLLGFCLEGEEKILV 419
+ H ++V+L+G E I++
Sbjct: 66 RQFDHPHIVKLIGVITENPVWIIM 89
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 35.4 bits (80), Expect = 0.057, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSASSGQGAQE-FKNEVVLV 395
E+ + +GEG FG+V++G+ S + +A+K + +E F E + +
Sbjct: 6 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 396 AKLQHRNLVRLLGFCLEGEEKILV 419
+ H ++V+L+G E I++
Sbjct: 66 RQFDHPHIVKLIGVITENPVWIIM 89
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 35.4 bits (80), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSASSGQGAQE-FKNEVVLV 395
E+ + +GEG FG+V++G+ S + +A+K + +E F E + +
Sbjct: 34 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 93
Query: 396 AKLQHRNLVRLLGFCLEGEEKILV 419
+ H ++V+L+G E I++
Sbjct: 94 RQFDHPHIVKLIGVITENPVWIIM 117
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 35.4 bits (80), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 42/88 (47%), Gaps = 3/88 (3%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQH 400
++ + +LG+G F V + V + G E A K ++ S + Q+ + E + KLQH
Sbjct: 4 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL 428
N+VRL E LV++ V L
Sbjct: 64 PNIVRLHDSIQEESFHYLVFDLVTGGEL 91
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 35.4 bits (80), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 26/88 (29%), Positives = 42/88 (47%), Gaps = 3/88 (3%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQH 400
++ + +LG+G F V + V + G E A K ++ S + Q+ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL 428
N+VRL E LV++ V L
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL 92
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 35.4 bits (80), Expect = 0.059, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 9/86 (10%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAV----KRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
+LG+G FG+VYK +E +V K + S + +++ E+ ++A H N+V+LL
Sbjct: 44 ELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 408 -GFCLEGEEKILVYEFVPNKSLDYFL 432
F E IL+ EF ++D +
Sbjct: 101 DAFYYENNLWILI-EFCAGGAVDAVM 125
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 35.4 bits (80), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 9/86 (10%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAV----KRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
+LG+G FG+VYK +E +V K + S + +++ E+ ++A H N+V+LL
Sbjct: 44 ELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 408 -GFCLEGEEKILVYEFVPNKSLDYFL 432
F E IL+ EF ++D +
Sbjct: 101 DAFYYENNLWILI-EFCAGGAVDAVM 125
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 35.4 bits (80), Expect = 0.062, Method: Compositional matrix adjust.
Identities = 23/80 (28%), Positives = 39/80 (48%), Gaps = 2/80 (2%)
Query: 346 KFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVLVAKLQHRNL 403
K+ K+GEG +G VYK G+ A+K RL E+ ++ +L+H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 404 VRLLGFCLEGEEKILVYEFV 423
V+L + +LV+E +
Sbjct: 63 VKLYDVIHTKKRLVLVFEHL 82
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 35.4 bits (80), Expect = 0.064, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 9/86 (10%)
Query: 352 KLGEGGFGEVYKGVLPSGQEIAV----KRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLL 407
+LG+G FG+VYK +E +V K + S + +++ E+ ++A H N+V+LL
Sbjct: 44 ELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 408 -GFCLEGEEKILVYEFVPNKSLDYFL 432
F E IL+ EF ++D +
Sbjct: 101 DAFYYENNLWILI-EFCAGGAVDAVM 125
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 35.4 bits (80), Expect = 0.066, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSASSGQGAQE-FKNEVVLV 395
E+ + +GEG FG+V++G+ S + +A+K + +E F E + +
Sbjct: 6 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 65
Query: 396 AKLQHRNLVRLLGFCLEGEEKILV 419
+ H ++V+L+G E I++
Sbjct: 66 RQFDHPHIVKLIGVITENPVWIIM 89
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 35.4 bits (80), Expect = 0.066, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSASSGQGAQE-FKNEVVLV 395
E+ + +GEG FG+V++G+ S + +A+K + +E F E + +
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70
Query: 396 AKLQHRNLVRLLGFCLEGEEKILV 419
+ H ++V+L+G E I++
Sbjct: 71 RQFDHPHIVKLIGVITENPVWIIM 94
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 35.4 bits (80), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSASSGQGAQE-FKNEVVLV 395
E+ + +GEG FG+V++G+ S + +A+K + +E F E + +
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 62
Query: 396 AKLQHRNLVRLLGFCLEGEEKILV 419
+ H ++V+L+G E I++
Sbjct: 63 RQFDHPHIVKLIGVITENPVWIIM 86
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 35.4 bits (80), Expect = 0.068, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 12/93 (12%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSGQGAQEFKN--EVVLVAKL 398
A ++ ++GEG +G+V+K + G+ +A+KR+ +G+ EV ++ L
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 399 ---QHRNLVRLLGFC----LEGEEKI-LVYEFV 423
+H N+VRL C + E K+ LV+E V
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 101
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 35.4 bits (80), Expect = 0.070, Method: Compositional matrix adjust.
Identities = 25/83 (30%), Positives = 41/83 (49%), Gaps = 3/83 (3%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPS-GQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQH 400
++ + +LG+G F V + V + G E A K ++ S + Q+ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 401 RNLVRLLGFCLEGEEKILVYEFV 423
N+VRL E LV++ V
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLV 87
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 35.0 bits (79), Expect = 0.072, Method: Compositional matrix adjust.
Identities = 28/92 (30%), Positives = 44/92 (47%), Gaps = 12/92 (13%)
Query: 348 STDNKLGEGGFGEVYKG-VLPSGQ---EIAVKRLS-ASSGQGAQEFKNEVVLVAKLQHRN 402
+D +G+G FG VY G + Q + A+K LS + Q + F E +L+ L H N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 403 LVRLLGFCLEGEEKILVYEFVPNKSLDYFLYG 434
++ L+G L E +P+ L Y +G
Sbjct: 84 VLALIGIMLPPEG-------LPHVLLPYMCHG 108
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 35.0 bits (79), Expect = 0.073, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSASSGQGAQE-FKNEVVLV 395
E+ + +GEG FG+V++G+ S + +A+K + +E F E + +
Sbjct: 8 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 67
Query: 396 AKLQHRNLVRLLGFCLEGEEKILV 419
+ H ++V+L+G E I++
Sbjct: 68 RQFDHPHIVKLIGVITENPVWIIM 91
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 35.0 bits (79), Expect = 0.075, Method: Compositional matrix adjust.
Identities = 26/85 (30%), Positives = 42/85 (49%), Gaps = 13/85 (15%)
Query: 326 DLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQG 384
DL+ L FE +E+ +G G +G+VYKG + +GQ A+K + +G
Sbjct: 15 DLSALRDPAGIFELVEL----------VGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDE 63
Query: 385 AQEFKNEVVLVAKL-QHRNLVRLLG 408
+E K E+ ++ K HRN+ G
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYG 88
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 35.0 bits (79), Expect = 0.077, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 12/93 (12%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSGQGAQEFKN--EVVLVAKL 398
A ++ ++GEG +G+V+K + G+ +A+KR+ +G+ EV ++ L
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 399 ---QHRNLVRLLGFC----LEGEEKI-LVYEFV 423
+H N+VRL C + E K+ LV+E V
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 101
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 35.0 bits (79), Expect = 0.077, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 7/88 (7%)
Query: 343 ATNKFSTD----NKLGEGGFGEVYKGVLPS-GQEIAVKRLSAS--SGQGAQEFKNEVVLV 395
A+ KFS + +LG+G F V + V + G E A K ++ S + Q+ + E +
Sbjct: 23 ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC 82
Query: 396 AKLQHRNLVRLLGFCLEGEEKILVYEFV 423
KLQH N+VRL E LV++ V
Sbjct: 83 RKLQHPNIVRLHDSIQEESFHYLVFDLV 110
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 35.0 bits (79), Expect = 0.077, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 341 EVATNKFSTDN-----KLGEGGFGEVYKGVLPSGQEI-AVKRL--SASSGQGAQ-EFKNE 391
E+ KF+ D+ LG+G FG VY + I A+K L S +G + + + E
Sbjct: 5 EMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
+ + + L+H N++R+ + + + L+ EF P L
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 101
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 35.0 bits (79), Expect = 0.079, Method: Compositional matrix adjust.
Identities = 27/93 (29%), Positives = 48/93 (51%), Gaps = 12/93 (12%)
Query: 343 ATNKFSTDNKLGEGGFGEVYKG--VLPSGQEIAVKRLSASSGQGAQEFKN--EVVLVAKL 398
A ++ ++GEG +G+V+K + G+ +A+KR+ +G+ EV ++ L
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 399 ---QHRNLVRLLGFC----LEGEEKI-LVYEFV 423
+H N+VRL C + E K+ LV+E V
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 101
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 35.0 bits (79), Expect = 0.080, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSASSGQGAQE-FKNEVVLV 395
E+ + +GEG FG+V++G+ S + +A+K + +E F E + +
Sbjct: 9 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 68
Query: 396 AKLQHRNLVRLLGFCLEGEEKILV 419
+ H ++V+L+G E I++
Sbjct: 69 RQFDHPHIVKLIGVITENPVWIIM 92
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 35.0 bits (79), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 341 EVATNKFSTDN-----KLGEGGFGEVYKGVLPSGQEI-AVKRL--SASSGQGAQ-EFKNE 391
E+ KF+ D+ LG+G FG VY + I A+K L S +G + + + E
Sbjct: 6 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 65
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
+ + + L+H N++R+ + + + L+ EF P L
Sbjct: 66 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 102
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 35.0 bits (79), Expect = 0.081, Method: Compositional matrix adjust.
Identities = 27/97 (27%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 341 EVATNKFSTDN-----KLGEGGFGEVYKGVLPSGQEI-AVKRL--SASSGQGAQ-EFKNE 391
E+ KF+ D+ LG+G FG VY + I A+K L S +G + + + E
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 392 VVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
+ + + L+H N++R+ + + + L+ EF P L
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 101
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 35.0 bits (79), Expect = 0.088, Method: Compositional matrix adjust.
Identities = 22/80 (27%), Positives = 39/80 (48%), Gaps = 4/80 (5%)
Query: 347 FSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKN---EVVLVAKLQHRN 402
F + K+G G F EVY+ L G +A+K++ A+ + E+ L+ +L H N
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 403 LVRLLGFCLEGEEKILVYEF 422
+++ +E E +V E
Sbjct: 94 VIKYYASFIEDNELNIVLEL 113
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 34.7 bits (78), Expect = 0.097, Method: Compositional matrix adjust.
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 12/116 (10%)
Query: 316 NAVPEENADNDLTILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK 375
N V D+ +++ L D +T E ++ +G G FG V++ L E+A+K
Sbjct: 11 NGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK 70
Query: 376 RLSASSGQGAQEFKN-EVVLVAKLQHRNLVRLLGFCLEGEEKI------LVYEFVP 424
++ + FKN E+ ++ ++H N+V L F +K LV E+VP
Sbjct: 71 KVLQD-----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 34.7 bits (78), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSASSGQGAQE-FKNEVVLV 395
E+ + +GEG FG+V++G+ S + +A+K + +E F E + +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 396 AKLQHRNLVRLLGFCLEGEEKILV 419
+ H ++V+L+G E I++
Sbjct: 446 RQFDHPHIVKLIGVITENPVWIIM 469
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 34.7 bits (78), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 20/84 (23%), Positives = 41/84 (48%), Gaps = 5/84 (5%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQE----IAVKRLSASSGQGAQE-FKNEVVLV 395
E+ + +GEG FG+V++G+ S + +A+K + +E F E + +
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM 445
Query: 396 AKLQHRNLVRLLGFCLEGEEKILV 419
+ H ++V+L+G E I++
Sbjct: 446 RQFDHPHIVKLIGVITENPVWIIM 469
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 34.7 bits (78), Expect = 0.11, Method: Compositional matrix adjust.
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 16/87 (18%)
Query: 328 TILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQ 386
T+ + DF+ IE+ +G GGFG+V+K G+ +KR+ ++ + +
Sbjct: 4 TVDKRFGMDFKEIEL----------IGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER 53
Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEG 413
E K +AKL H N+V G C +G
Sbjct: 54 EVK----ALAKLDHVNIVHYNG-CWDG 75
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 34.3 bits (77), Expect = 0.15, Method: Compositional matrix adjust.
Identities = 21/67 (31%), Positives = 39/67 (58%), Gaps = 4/67 (5%)
Query: 346 KFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRL--SASSGQGAQEFKNEVVLVAKLQ-HR 401
K+ KLG+G +G V+K + +G+ +AVK++ + + AQ E++++ +L H
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 402 NLVRLLG 408
N+V LL
Sbjct: 70 NIVNLLN 76
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 33.9 bits (76), Expect = 0.16, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 74 REGNIQYLFLEY 85
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 33.9 bits (76), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 28/103 (27%), Positives = 49/103 (47%), Gaps = 22/103 (21%)
Query: 328 TILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSASSGQGAQ 386
T+ + DF+ IE+ +G GGFG+V+K G+ ++R+ ++ + +
Sbjct: 5 TVDKRFGMDFKEIEL----------IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER 54
Query: 387 EFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLD 429
E K +AKL H N+V G C +G +++ P S D
Sbjct: 55 EVK----ALAKLDHVNIVHYNG-CWDG------FDYDPETSDD 86
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 33.9 bits (76), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 73 REGNIQYLFLEY 84
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 33.9 bits (76), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 75 REGNIQYLFLEY 86
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 3/81 (3%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGA--QEFKNEVVLVAKLQHR 401
K+ K+GEG +G V+K +GQ +A+K+ S + E+ ++ +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 402 NLVRLLGFCLEGEEKILVYEF 422
NLV LL LV+E+
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEY 83
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 74 REGNIQYLFLEY 85
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 74 REGNIQYLFLEY 85
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 33.9 bits (76), Expect = 0.18, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 74 REGNIQYLFLEY 85
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 74 REGNIQYLFLEY 85
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 75 REGNIQYLFLEY 86
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 75 REGNIQYLFLEY 86
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 74 REGNIQYLFLEY 85
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 33.9 bits (76), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 74 REGNIQYLFLEY 85
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 33.9 bits (76), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 74 REGNIQYLFLEY 85
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 33.9 bits (76), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 74 REGNIQYLFLEY 85
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 33.9 bits (76), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 74 REGNIQYLFLEY 85
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 33.9 bits (76), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 75 REGNIQYLFLEY 86
>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567
pdb|4HNI|B Chain B, Crystal Structure Of Ck1e In Complex With Pf4800567
pdb|4HOK|A Chain A, Crystal Structure Of Apo Ck1e
pdb|4HOK|C Chain C, Crystal Structure Of Apo Ck1e
pdb|4HOK|E Chain E, Crystal Structure Of Apo Ck1e
pdb|4HOK|G Chain G, Crystal Structure Of Apo Ck1e
pdb|4HOK|I Chain I, Crystal Structure Of Apo Ck1e
pdb|4HOK|K Chain K, Crystal Structure Of Apo Ck1e
pdb|4HOK|M Chain M, Crystal Structure Of Apo Ck1e
pdb|4HOK|O Chain O, Crystal Structure Of Apo Ck1e
pdb|4HOK|Q Chain Q, Crystal Structure Of Apo Ck1e
pdb|4HOK|S Chain S, Crystal Structure Of Apo Ck1e
pdb|4HOK|U Chain U, Crystal Structure Of Apo Ck1e
pdb|4HOK|W Chain W, Crystal Structure Of Apo Ck1e
Length = 296
Score = 33.5 bits (75), Expect = 0.22, Method: Compositional matrix adjust.
Identities = 14/32 (43%), Positives = 22/32 (68%), Gaps = 1/32 (3%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK 375
NK+ K+G G FG++Y G + SG+E+A+K
Sbjct: 9 NKYRLGRKIGSGSFGDIYLGANIASGEEVAIK 40
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 33.5 bits (75), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 75 REGNIQYLFLEY 86
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 33.5 bits (75), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 75 REGNIQYLFLEY 86
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 33.5 bits (75), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 74 REGNIQYLFLEY 85
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 33.5 bits (75), Expect = 0.23, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 34/72 (47%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG +GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 75 REGNIQYLFLEY 86
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 33.5 bits (75), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 19/80 (23%), Positives = 37/80 (46%), Gaps = 1/80 (1%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL 403
+ + +LG G FG V++ +G A K + + + E+ ++ L+H L
Sbjct: 51 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 404 VRLLGFCLEGEEKILVYEFV 423
V L + E +++YEF+
Sbjct: 111 VNLHDAFEDDNEMVMIYEFM 130
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 33.5 bits (75), Expect = 0.26, Method: Compositional matrix adjust.
Identities = 19/80 (23%), Positives = 37/80 (46%), Gaps = 1/80 (1%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL 403
+ + +LG G FG V++ +G A K + + + E+ ++ L+H L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 404 VRLLGFCLEGEEKILVYEFV 423
V L + E +++YEF+
Sbjct: 217 VNLHDAFEDDNEMVMIYEFM 236
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 33.1 bits (74), Expect = 0.29, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GV--LPSGQEIAVKRLS--ASSG 382
E L +D E ++ + LG G FG+V + G+ + + +AVK L A+
Sbjct: 13 ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 33.1 bits (74), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 22/57 (38%), Positives = 32/57 (56%), Gaps = 3/57 (5%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSASSGQGAQ--EFKNEVVLVAKLQHRNLVRL 406
LG+G FGEV K + QE AVK ++ +S + EV L+ KL H N+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 33.1 bits (74), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 50/111 (45%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ + LG G FG+V + G+ + + +AVK L A+
Sbjct: 14 ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 73
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 74 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 124
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 33.1 bits (74), Expect = 0.33, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 33.1 bits (74), Expect = 0.34, Method: Compositional matrix adjust.
Identities = 22/57 (38%), Positives = 32/57 (56%), Gaps = 3/57 (5%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSASSGQGAQ--EFKNEVVLVAKLQHRNLVRL 406
LG+G FGEV K + QE AVK ++ +S + EV L+ KL H N+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 33.1 bits (74), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 15 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 74
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 75 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 33.1 bits (74), Expect = 0.35, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 22/57 (38%), Positives = 32/57 (56%), Gaps = 3/57 (5%)
Query: 353 LGEGGFGEVYK-GVLPSGQEIAVKRLSASSGQGAQ--EFKNEVVLVAKLQHRNLVRL 406
LG+G FGEV K + QE AVK ++ +S + EV L+ KL H N+++L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 32.7 bits (73), Expect = 0.36, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 50 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 109
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 110 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 160
>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant
Length = 483
Score = 32.7 bits (73), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 44/88 (50%), Gaps = 2/88 (2%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNL 403
NKF K+G G FGE+Y G + + +E+A+K + + +++++ + + +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ-GGTGI 65
Query: 404 VRLLGFCLEGEEKILVYEFVPNKSLDYF 431
+ F +EG+ +LV + + D F
Sbjct: 66 PNVRWFGVEGDYNVLVMDLLGPSLEDLF 93
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 32.7 bits (73), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 4 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 64 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 114
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 32.7 bits (73), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 32.7 bits (73), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 4 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 64 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 32.7 bits (73), Expect = 0.41, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 4 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 64 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 32.7 bits (73), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 91 MEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 32.7 bits (73), Expect = 0.42, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 4 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 63
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 64 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYL 114
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 32.7 bits (73), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 9/101 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GV--LPSGQEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 15 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 74
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEF 422
+ +L+ H N+V LLG C + G +++ EF
Sbjct: 75 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 115
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 32.3 bits (72), Expect = 0.47, Method: Compositional matrix adjust.
Identities = 27/101 (26%), Positives = 46/101 (45%), Gaps = 9/101 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GV--LPSGQEIAVKRLS--ASSG 382
E L +D E ++ + LG G FG+V + G+ + + +AVK L A+
Sbjct: 13 ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHS 72
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEF 422
+ +L+ H N+V LLG C + G +++ EF
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 113
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 32.3 bits (72), Expect = 0.48, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 32.3 bits (72), Expect = 0.50, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 6 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 65
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 66 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 116
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 32.3 bits (72), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 8 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 67
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 68 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 32.3 bits (72), Expect = 0.51, Method: Compositional matrix adjust.
Identities = 23/73 (31%), Positives = 38/73 (52%), Gaps = 6/73 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVA 396
+ ++++ LG+G FGEV K + +GQE AVK +S + EV L+
Sbjct: 29 IFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 397 KLQHRNLVRLLGF 409
+L H N+++L F
Sbjct: 88 QLDHPNIMKLYEF 100
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 32.3 bits (72), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 32.3 bits (72), Expect = 0.54, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 32.3 bits (72), Expect = 0.55, Method: Compositional matrix adjust.
Identities = 22/75 (29%), Positives = 42/75 (56%), Gaps = 13/75 (17%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVL----PSGQEIAVKRLSAS--SGQGAQEFKN 390
F+++E K+ K+GEG FG K +L G++ +K ++ S S + +E +
Sbjct: 20 FQSME----KYVRLQKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRR 72
Query: 391 EVVLVAKLQHRNLVR 405
EV ++A ++H N+V+
Sbjct: 73 EVAVLANMKHPNIVQ 87
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 32.3 bits (72), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 19/64 (29%), Positives = 36/64 (56%), Gaps = 3/64 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSA--SSGQGAQEFKNEVVLVAKLQHRNL 403
+ + +G G +G V + SG+++A+K+LS S A+ E++L+ +QH N+
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 404 VRLL 407
+ LL
Sbjct: 86 IGLL 89
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 32.3 bits (72), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 27/86 (31%), Positives = 37/86 (43%), Gaps = 16/86 (18%)
Query: 334 QFDFETIEVATNKFSTDNK-------LGEGGFGEVYKG------VLPSGQEIAVKRLSAS 380
Q D E +E S D + +G G F VYKG V + E+ ++L+ S
Sbjct: 8 QDDIEELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS 67
Query: 381 SGQGAQEFKNEVVLVAKLQHRNLVRL 406
Q FK E + LQH N+VR
Sbjct: 68 E---RQRFKEEAEXLKGLQHPNIVRF 90
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 32.3 bits (72), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 13 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 72
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 73 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 32.3 bits (72), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 18/50 (36%), Positives = 28/50 (56%), Gaps = 1/50 (2%)
Query: 339 TIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQE 387
++EV + +LG G +G V K +PSGQ +AVKR+ A+ Q+
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK 50
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 32.3 bits (72), Expect = 0.58, Method: Compositional matrix adjust.
Identities = 23/73 (31%), Positives = 38/73 (52%), Gaps = 6/73 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVA 396
+ ++++ LG+G FGEV K + +GQE AVK +S + EV L+
Sbjct: 23 IFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 397 KLQHRNLVRLLGF 409
+L H N+++L F
Sbjct: 82 QLDHPNIMKLYEF 94
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 32.3 bits (72), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 19/64 (29%), Positives = 36/64 (56%), Gaps = 3/64 (4%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP-SGQEIAVKRLSA--SSGQGAQEFKNEVVLVAKLQHRNL 403
+ + +G G +G V + SG+++A+K+LS S A+ E++L+ +QH N+
Sbjct: 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 103
Query: 404 VRLL 407
+ LL
Sbjct: 104 IGLL 107
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 32.3 bits (72), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 29/111 (26%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 331 ESLQFDFETIEVATNKFSTDNKLGEGGFGEVYK----GVLPSG--QEIAVKRLS--ASSG 382
E L +D E ++ LG G FG+V + G+ + + +AVK L A+
Sbjct: 15 ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS 74
Query: 383 QGAQEFKNEVVLVAKLQHRNLVRLLGFCLE-GEEKILVYEFVPNKSLDYFL 432
+ +L+ H N+V LLG C + G +++ EF +L +L
Sbjct: 75 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 125
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 32.0 bits (71), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(ttk)
pdb|3GFW|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrolo-Pyridin Ligand
Length = 313
Score = 32.0 bits (71), Expect = 0.60, Method: Compositional matrix adjust.
Identities = 21/89 (23%), Positives = 44/89 (49%), Gaps = 4/89 (4%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVL 394
F+++ V +S ++G GG +V++ + Q A+K L + Q ++NE+
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 395 VAKLQHRN--LVRLLGFCLEGEEKILVYE 421
+ KLQ + ++RL + + + +V E
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVME 108
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 32.0 bits (71), Expect = 0.61, Method: Compositional matrix adjust.
Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 9/91 (9%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAV-----KRLSASSGQGAQEFKNEVVLVAK 397
T ++ +LG+G F V + V + +GQE A K+LSA + Q+ + E +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA---RDHQKLEREARICRL 66
Query: 398 LQHRNLVRLLGFCLEGEEKILVYEFVPNKSL 428
L+H N+VRL E L+++ V L
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL 97
>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrimido-Diazepin Ligand
Length = 313
Score = 32.0 bits (71), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 21/89 (23%), Positives = 44/89 (49%), Gaps = 4/89 (4%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVL 394
F+++ V +S ++G GG +V++ + Q A+K L + Q ++NE+
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 395 VAKLQHRN--LVRLLGFCLEGEEKILVYE 421
+ KLQ + ++RL + + + +V E
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVME 108
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 32.0 bits (71), Expect = 0.63, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 32.0 bits (71), Expect = 0.65, Method: Compositional matrix adjust.
Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 3/81 (3%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQHRNLVRLL 407
+LG+G F V + V + +GQE A K ++ S + Q+ + E + L+H N+VRL
Sbjct: 28 EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 408 GFCLEGEEKILVYEFVPNKSL 428
E L+++ V L
Sbjct: 88 DSISEEGHHYLIFDLVTGGEL 108
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 32.0 bits (71), Expect = 0.66, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 91 MEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYL 132
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 32.0 bits (71), Expect = 0.73, Method: Compositional matrix adjust.
Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 8/78 (10%)
Query: 353 LGEGGFGEVYK----GVLPSGQ--EIAVKRLSASSGQGAQE-FKNEVVLVAKL-QHRNLV 404
LG G FG+V G+ +G ++AVK L + +E +E+ ++ +L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 405 RLLGFCLEGEEKILVYEF 422
LLG C L++E+
Sbjct: 113 NLLGACTLSGPIYLIFEY 130
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 32.0 bits (71), Expect = 0.76, Method: Compositional matrix adjust.
Identities = 24/72 (33%), Positives = 33/72 (45%), Gaps = 2/72 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLVRLLGFC 410
LGEG GEV V +E +AVK + E K E+ + L H N+V+ G
Sbjct: 14 LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 411 LEGEEKILVYEF 422
EG + L E+
Sbjct: 74 REGNIQYLFLEY 85
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 31.6 bits (70), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 19/51 (37%), Positives = 26/51 (50%), Gaps = 1/51 (1%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQE 387
E EV + +LG G +G V K +PSGQ AVKR+ A+ Q+
Sbjct: 27 ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQK 77
>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing
Residues 1-317 Complex With Bound Tungstate
pdb|1CKJ|B Chain B, Casein Kinase I Delta Truncation Mutant Containing
Residues 1-317 Complex With Bound Tungstate
pdb|1CKI|A Chain A, Recombinant Casein Kinase I Delta Truncation Mutant
Containing Residues 1-317
pdb|1CKI|B Chain B, Recombinant Casein Kinase I Delta Truncation Mutant
Containing Residues 1-317
Length = 317
Score = 31.6 bits (70), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 12/32 (37%), Positives = 22/32 (68%), Gaps = 1/32 (3%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK 375
N++ K+G G FG++Y G + +G+E+A+K
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK 38
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 31.6 bits (70), Expect = 0.82, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 3/88 (3%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQH 400
T+++ +G+G F V + V L +G E A K ++ S + Q+ + E + L+H
Sbjct: 3 TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL 428
N+VRL E LV++ V L
Sbjct: 63 SNIVRLHDSISEEGFHYLVFDLVTGGEL 90
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 31.6 bits (70), Expect = 0.84, Method: Compositional matrix adjust.
Identities = 20/74 (27%), Positives = 36/74 (48%), Gaps = 1/74 (1%)
Query: 351 NKLGEGGFGEVYKGV-LPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
+LG G FG V++ V +G+ K ++ KNE+ ++ +L H L+ L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 410 CLEGEEKILVYEFV 423
+ E +L+ EF+
Sbjct: 117 FEDKYEMVLILEFL 130
>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d
pdb|3UYS|B Chain B, Crystal Structure Of Apo Human Ck1d
pdb|3UYS|C Chain C, Crystal Structure Of Apo Human Ck1d
pdb|3UYS|D Chain D, Crystal Structure Of Apo Human Ck1d
pdb|3UYT|A Chain A, Crystal Structure Of Ck1d With Pf670462 From P1 Crystal
Form
pdb|3UYT|B Chain B, Crystal Structure Of Ck1d With Pf670462 From P1 Crystal
Form
pdb|3UYT|C Chain C, Crystal Structure Of Ck1d With Pf670462 From P1 Crystal
Form
pdb|3UYT|D Chain D, Crystal Structure Of Ck1d With Pf670462 From P1 Crystal
Form
pdb|3UZP|A Chain A, Crystal Structure Of Ck1d With Pf670462 From P21 Crystal
Form
pdb|3UZP|B Chain B, Crystal Structure Of Ck1d With Pf670462 From P21 Crystal
Form
pdb|4HNF|A Chain A, Crystal Structure Of Ck1d In Complex With Pf4800567
pdb|4HNF|B Chain B, Crystal Structure Of Ck1d In Complex With Pf4800567
pdb|4HGT|A Chain A, Crystal Structure Of Ck1d With Compound 13
pdb|4HGT|B Chain B, Crystal Structure Of Ck1d With Compound 13
Length = 296
Score = 31.6 bits (70), Expect = 0.87, Method: Compositional matrix adjust.
Identities = 12/32 (37%), Positives = 22/32 (68%), Gaps = 1/32 (3%)
Query: 345 NKFSTDNKLGEGGFGEVYKGV-LPSGQEIAVK 375
N++ K+G G FG++Y G + +G+E+A+K
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK 40
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 31.6 bits (70), Expect = 0.87, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 49/102 (48%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E+ ++ LGEG FG+V K ++AVK L S ++ + + +E
Sbjct: 9 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 68
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 69 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 110
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 31.6 bits (70), Expect = 0.91, Method: Compositional matrix adjust.
Identities = 23/73 (31%), Positives = 38/73 (52%), Gaps = 6/73 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVA 396
+ ++++ LG+G FGEV K + +GQE AVK +S + EV L+
Sbjct: 46 IFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLK 104
Query: 397 KLQHRNLVRLLGF 409
+L H N+++L F
Sbjct: 105 QLDHPNIMKLYEF 117
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 31.6 bits (70), Expect = 0.95, Method: Compositional matrix adjust.
Identities = 25/105 (23%), Positives = 50/105 (47%), Gaps = 16/105 (15%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSG-----------QEIAVKRL-SASSGQGAQEF 388
E+ ++ LGEG FG+V VL ++AVK L S ++ + +
Sbjct: 24 ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 80
Query: 389 KNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+E+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 81 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 31.6 bits (70), Expect = 0.96, Method: Compositional matrix adjust.
Identities = 23/73 (31%), Positives = 38/73 (52%), Gaps = 6/73 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVA 396
+ ++++ LG+G FGEV K + +GQE AVK +S + EV L+
Sbjct: 47 IFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLK 105
Query: 397 KLQHRNLVRLLGF 409
+L H N+++L F
Sbjct: 106 QLDHPNIMKLYEF 118
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 31.6 bits (70), Expect = 0.98, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 31.6 bits (70), Expect = 1.00, Method: Compositional matrix adjust.
Identities = 25/105 (23%), Positives = 50/105 (47%), Gaps = 16/105 (15%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSG-----------QEIAVKRL-SASSGQGAQEF 388
E+ ++ LGEG FG+V VL ++AVK L S ++ + +
Sbjct: 17 ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 73
Query: 389 KNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+E+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 74 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 118
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/105 (23%), Positives = 50/105 (47%), Gaps = 16/105 (15%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSG-----------QEIAVKRL-SASSGQGAQEF 388
E+ ++ LGEG FG+V VL ++AVK L S ++ + +
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 121
Query: 389 KNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+E+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 166
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 31.6 bits (70), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/105 (23%), Positives = 50/105 (47%), Gaps = 16/105 (15%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSG-----------QEIAVKRL-SASSGQGAQEF 388
E+ ++ LGEG FG+V VL ++AVK L S ++ + +
Sbjct: 13 ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 69
Query: 389 KNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+E+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 70 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 114
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 25/105 (23%), Positives = 50/105 (47%), Gaps = 16/105 (15%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSG-----------QEIAVKRL-SASSGQGAQEF 388
E+ ++ LGEG FG+V VL ++AVK L S ++ + +
Sbjct: 24 ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 80
Query: 389 KNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+E+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 81 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 31.2 bits (69), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 26/79 (32%), Positives = 37/79 (46%), Gaps = 12/79 (15%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQE-FKNEVV 393
DFE I+ LG GGFG V++ A+KR+ + + A+E EV
Sbjct: 6 DFEPIQC----------LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 55
Query: 394 LVAKLQHRNLVRLLGFCLE 412
+AKL+H +VR LE
Sbjct: 56 ALAKLEHPGIVRYFNAWLE 74
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/105 (23%), Positives = 50/105 (47%), Gaps = 16/105 (15%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSG-----------QEIAVKRL-SASSGQGAQEF 388
E+ ++ LGEG FG+V VL ++AVK L S ++ + +
Sbjct: 16 ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 72
Query: 389 KNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+E+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 73 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 117
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/105 (23%), Positives = 50/105 (47%), Gaps = 16/105 (15%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSG-----------QEIAVKRL-SASSGQGAQEF 388
E+ ++ LGEG FG+V VL ++AVK L S ++ + +
Sbjct: 24 ELPRDRLVLGKPLGEGAFGQV---VLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 80
Query: 389 KNEVVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+E+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 81 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 25/79 (31%), Positives = 37/79 (46%), Gaps = 12/79 (15%)
Query: 336 DFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQE-FKNEVV 393
DFE I+ +G GGFG V++ A+KR+ + + A+E EV
Sbjct: 7 DFEPIQC----------MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK 56
Query: 394 LVAKLQHRNLVRLLGFCLE 412
+AKL+H +VR LE
Sbjct: 57 ALAKLEHPGIVRYFNAWLE 75
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 31.2 bits (69), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 49/102 (48%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E+ ++ LGEG FG+V K ++AVK L S ++ + + +E
Sbjct: 24 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 83
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 84 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 125
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 19/56 (33%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 353 LGEGGFGEVY--KGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LG G F EV+ K L +G+ A+K + S +NE+ ++ K++H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 31.2 bits (69), Expect = 1.2, Method: Compositional matrix adjust.
Identities = 23/73 (31%), Positives = 37/73 (50%), Gaps = 6/73 (8%)
Query: 342 VATNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVA 396
+ ++++ LG+G FGEV K + +GQE AVK +S + EV L+
Sbjct: 23 IFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 397 KLQHRNLVRLLGF 409
+L H N+ +L F
Sbjct: 82 QLDHPNIXKLYEF 94
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 31.2 bits (69), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 19 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 79 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 108
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 31.2 bits (69), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 23 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 82
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 83 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 124
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 31.2 bits (69), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 18 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 77
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 78 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 119
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 31.2 bits (69), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 10/85 (11%)
Query: 344 TNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLSAS-----SGQGAQEFKNEVVLVA 396
++++ KLG G +GEV K L +G E A+K + S S GA +EV ++
Sbjct: 20 SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGA--LLDEVAVLK 76
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYE 421
+L H N+++L F + LV E
Sbjct: 77 QLDHPNIMKLYEFFEDKRNYYLVME 101
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 31.2 bits (69), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 32 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 92 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 121
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 30.8 bits (68), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 19 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 78
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 79 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 108
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 24/102 (23%), Positives = 47/102 (46%), Gaps = 10/102 (9%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 20 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 79
Query: 392 VVLVAKL-QHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+ ++ + +H+N++ LLG C + ++ E+ +L +L
Sbjct: 80 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 121
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 21/57 (36%), Positives = 33/57 (57%), Gaps = 5/57 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
+G+G FGEV++G G+E+AVK S S + + + E+ L+H N +LGF
Sbjct: 12 IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHEN---ILGF 63
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 18/51 (35%), Positives = 27/51 (52%), Gaps = 1/51 (1%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKG-VLPSGQEIAVKRLSASSGQGAQE 387
+ EV + +LG G +G V K +PSGQ +AVKR+ A+ Q+
Sbjct: 44 QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK 94
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 20 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 80 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 109
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 32 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 92 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 121
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 33 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 93 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 122
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 30.8 bits (68), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 33 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 93 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 122
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 33 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 93 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 122
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 47 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 136
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 32 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 92 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 121
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 21/57 (36%), Positives = 33/57 (57%), Gaps = 5/57 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
+G+G FGEV++G G+E+AVK S S + + + E+ L+H N +LGF
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHEN---ILGF 62
>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With Atp
pdb|3HMO|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With The Inhibitor Staurosporine
pdb|3HMP|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With A Quinazolin Ligand Compound 4
Length = 342
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVLV 395
E I V +S ++G GG +V++ + Q A+K L + Q ++NE+ +
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 396 AKLQHRN--LVRLLGFCLEGEEKILVYE 421
KLQ + ++RL + + + +V E
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME 136
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 47 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 106
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 107 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 136
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 33 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 92
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 93 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 122
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 32 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 91
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 92 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 121
>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715
Length = 317
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVLV 395
E I V +S ++G GG +V++ + Q A+K L + Q ++NE+ +
Sbjct: 5 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 64
Query: 396 AKLQHRN--LVRLLGFCLEGEEKILVYE 421
KLQ + ++RL + + + +V E
Sbjct: 65 NKLQQHSDKIIRLYDYEITDQYIYMVME 92
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 5 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 65 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 94
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 21/57 (36%), Positives = 33/57 (57%), Gaps = 5/57 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
+G+G FGEV++G G+E+AVK S S + + + E+ L+H N +LGF
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHEN---ILGF 101
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 20 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 80 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 109
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 20 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 79
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 80 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 109
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 21/57 (36%), Positives = 33/57 (57%), Gaps = 5/57 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
+G+G FGEV++G G+E+AVK S S + + + E+ L+H N +LGF
Sbjct: 37 IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHEN---ILGF 88
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 30.8 bits (68), Expect = 1.5, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 5 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 65 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 94
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 4 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 64 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 93
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 99 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 128
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 4 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 63
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 64 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 93
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 30.8 bits (68), Expect = 1.6, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 52 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 111
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 112 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 141
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 22/58 (37%), Positives = 33/58 (56%), Gaps = 7/58 (12%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKN-EVVLVAKLQHRNLVRLLGF 409
+G+G FGEV++G G+E+AVK SS + F+ E+ L+H N +LGF
Sbjct: 17 IGKGRFGEVWRGKW-RGEEVAVKIF--SSREERSWFREAEIYQTVMLRHEN---ILGF 68
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 3 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 62
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 63 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 92
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 21/57 (36%), Positives = 33/57 (57%), Gaps = 5/57 (8%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGF 409
+G+G FGEV++G G+E+AVK S S + + + E+ L+H N +LGF
Sbjct: 14 IGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHEN---ILGF 65
>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain
Length = 343
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVLV 395
E I V +S ++G GG +V++ + Q A+K L + Q ++NE+ +
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61
Query: 396 AKLQHRN--LVRLLGFCLEGEEKILVYE 421
KLQ + ++RL + + + +V E
Sbjct: 62 NKLQQHSDKIIRLYDYEITDQYIYMVME 89
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 5 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 64
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 65 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 94
>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2-
Yl)amino]benzamide
Length = 320
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVLV 395
E I V +S ++G GG +V++ + Q A+K L + Q ++NE+ +
Sbjct: 1 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 60
Query: 396 AKLQHRN--LVRLLGFCLEGEEKILVYE 421
KLQ + ++RL + + + +V E
Sbjct: 61 NKLQQHSDKIIRLYDYEITDQYIYMVME 88
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 30.4 bits (67), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 30.4 bits (67), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 10/85 (11%)
Query: 344 TNKFSTDNKLGEGGFGEVY--KGVLPSGQEIAVKRLSAS-----SGQGAQEFKNEVVLVA 396
++++ KLG G +GEV K L +G E A+K + S S GA +EV ++
Sbjct: 3 SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGA--LLDEVAVLK 59
Query: 397 KLQHRNLVRLLGFCLEGEEKILVYE 421
+L H N+++L F + LV E
Sbjct: 60 QLDHPNIMKLYEFFEDKRNYYLVME 84
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 9/90 (10%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVV 393
E +++ LG GGFG VY G+ S +A+K + E N EVV
Sbjct: 27 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 86
Query: 394 LVAKLQH--RNLVRLLGFCLEGEEKILVYE 421
L+ K+ ++RLL + + +L+ E
Sbjct: 87 LLKKVSSGFSGVIRLLDWFERPDSFVLILE 116
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 21/80 (26%), Positives = 38/80 (47%), Gaps = 10/80 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFC 410
+ ++ + +H+N++ LLG C
Sbjct: 91 MEMMKMIGKHKNIINLLGAC 110
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 9/86 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVVLVAK 397
+++ LG GGFG VY G+ S +A+K + E N EVVL+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 398 LQH--RNLVRLLGFCLEGEEKILVYE 421
+ ++RLL + + +L+ E
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILE 89
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 2/78 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLGFC 410
LG G F EV Q+ +A+K ++ + +G + +NE+ ++ K++H N+V L
Sbjct: 26 LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 411 LEGEEKILVYEFVPNKSL 428
G L+ + V L
Sbjct: 86 ESGGHLYLIMQLVSGGEL 103
>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a
Mutant In Complex With Sp600125 Inhibitor
Length = 390
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVLV 395
E I V +S ++G GG +V++ + Q A+K L + Q ++NE+ +
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 396 AKLQHRN--LVRLLGFCLEGEEKILVYE 421
KLQ + ++RL + + + +V E
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME 136
>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1
Catalytic Domain Apo Form
Length = 390
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 42/88 (47%), Gaps = 4/88 (4%)
Query: 338 ETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVK--RLSASSGQGAQEFKNEVVLV 395
E I V +S ++G GG +V++ + Q A+K L + Q ++NE+ +
Sbjct: 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 396 AKLQHRN--LVRLLGFCLEGEEKILVYE 421
KLQ + ++RL + + + +V E
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVME 136
>pdb|4AI6|A Chain A, Dynein Motor Domain - Adp Complex
pdb|4AI6|B Chain B, Dynein Motor Domain - Adp Complex
pdb|4AKG|A Chain A, Dynein Motor Domain - Atp Complex
pdb|4AKG|B Chain B, Dynein Motor Domain - Atp Complex
pdb|4AKH|A Chain A, Dynein Motor Domain - Amppnp Complex
pdb|4AKH|B Chain B, Dynein Motor Domain - Amppnp Complex
pdb|4AKI|A Chain A, Dynein Motor Domain - Luac Derivative
pdb|4AKI|B Chain B, Dynein Motor Domain - Luac Derivative
Length = 2695
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 15/36 (41%), Positives = 22/36 (61%), Gaps = 4/36 (11%)
Query: 116 PVSKDTIVWYDECLLRYS----NRYIFSTRETTRTV 147
P ++ ++ Y+EC RYS + Y+FS RE TR V
Sbjct: 1447 PFARASVHLYNECKARYSTGLQSHYLFSPRELTRLV 1482
>pdb|3QMZ|A Chain A, Crystal Structure Of The Cytoplasmic Dynein Heavy Chain
Motor Domain
pdb|3QMZ|B Chain B, Crystal Structure Of The Cytoplasmic Dynein Heavy Chain
Motor Domain
Length = 2486
Score = 30.4 bits (67), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 15/36 (41%), Positives = 22/36 (61%), Gaps = 4/36 (11%)
Query: 116 PVSKDTIVWYDECLLRYS----NRYIFSTRETTRTV 147
P ++ ++ Y+EC RYS + Y+FS RE TR V
Sbjct: 1228 PFARASVHLYNECKARYSTGLQSHYLFSPRELTRLV 1263
>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum
In Complex With Indirubin E804
pdb|3EB0|C Chain C, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum
In Complex With Indirubin E804
Length = 383
Score = 30.4 bits (67), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 24/82 (29%), Positives = 44/82 (53%), Gaps = 12/82 (14%)
Query: 340 IEVATNKFSTDNKLGEGGFG---EVYKGVLPSGQEIAVKRLSASSGQGAQEFKN-EVVLV 395
+E ++ K+S LG G FG EV+ + SG+ A+K++ +KN E+ ++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFD--IESGKRFALKKVLQDP-----RYKNRELDIM 54
Query: 396 AKLQHRNLVRLLG-FCLEGEEK 416
L H N+++L+ F G+E+
Sbjct: 55 KVLDHVNIIKLVDYFYTTGDEE 76
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 30.4 bits (67), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 2/78 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLGFC 410
LG G F EV Q+ +A+K ++ + +G + +NE+ ++ K++H N+V L
Sbjct: 26 LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 411 LEGEEKILVYEFVPNKSL 428
G L+ + V L
Sbjct: 86 ESGGHLYLIMQLVSGGEL 103
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 30.4 bits (67), Expect = 2.2, Method: Compositional matrix adjust.
Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 9/86 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVVLVAK 397
+++ LG GGFG VY G+ S +A+K + E N EVVL+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 398 LQH--RNLVRLLGFCLEGEEKILVYE 421
+ ++RLL + + +L+ E
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILE 89
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 30.4 bits (67), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 9/86 (10%)
Query: 345 NKFSTDNKLGEGGFGEVYKGVLPSGQ-EIAVKRLSASSGQGAQEFKN------EVVLVAK 397
+++ LG GGFG VY G+ S +A+K + E N EVVL+ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 398 LQH--RNLVRLLGFCLEGEEKILVYE 421
+ ++RLL + + +L+ E
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILE 89
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 30.0 bits (66), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 15/37 (40%), Positives = 24/37 (64%), Gaps = 1/37 (2%)
Query: 352 KLGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQE 387
++G G +G V K V PSGQ +AVKR+ ++ + Q+
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK 65
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 30.0 bits (66), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 14/23 (60%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVY 362
I + N FS +G GGFGEVY
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVY 206
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 30.0 bits (66), Expect = 2.3, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 14/23 (60%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVY 362
I + N FS +G GGFGEVY
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVY 206
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 30.0 bits (66), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 14/23 (60%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVY 362
I + N FS +G GGFGEVY
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVY 206
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 30.0 bits (66), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 12/23 (52%), Positives = 14/23 (60%)
Query: 340 IEVATNKFSTDNKLGEGGFGEVY 362
I + N FS +G GGFGEVY
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVY 205
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 30.0 bits (66), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 2/78 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLGFC 410
LG G F EV Q+ +A+K ++ + +G + +NE+ ++ K++H N+V L
Sbjct: 26 LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 411 LEGEEKILVYEFVPNKSL 428
G L+ + V L
Sbjct: 86 ESGGHLYLIMQLVSGGEL 103
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 30.0 bits (66), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 21/80 (26%), Positives = 38/80 (47%), Gaps = 10/80 (12%)
Query: 341 EVATNKFSTDNKLGEGGFGEVY--------KGVLPSGQEIAVKRL-SASSGQGAQEFKNE 391
E +K + LGEG FG+V K +AVK L ++ + + +E
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 392 VVLVAKL-QHRNLVRLLGFC 410
+ ++ + +H+N++ LLG C
Sbjct: 91 MEMMKMIGKHKNIINLLGAC 110
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 30.0 bits (66), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 2/78 (2%)
Query: 353 LGEGGFGEVYKGVLPSGQE-IAVKRLSASSGQGAQ-EFKNEVVLVAKLQHRNLVRLLGFC 410
LG G F EV Q+ +A+K ++ + +G + +NE+ ++ K++H N+V L
Sbjct: 26 LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 411 LEGEEKILVYEFVPNKSL 428
G L+ + V L
Sbjct: 86 ESGGHLYLIMQLVSGGEL 103
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 30.0 bits (66), Expect = 2.5, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 13 YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 30.0 bits (66), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 25/92 (27%), Positives = 42/92 (45%), Gaps = 13/92 (14%)
Query: 353 LGEGGFGEVYKGVLPSGQEIAVKRLSASSGQG---AQEFKNEVVL---------VAKLQH 400
+G+G +GEV++G L G+ +AVK S+ Q E N V+L + +
Sbjct: 16 VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTS 74
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
RN L E +Y+F+ ++L+ L
Sbjct: 75 RNSSTQLWLITHYHEHGSLYDFLQRQTLEPHL 106
>pdb|3FBX|A Chain A, Crystal Structure Of The Lysosomal 66.3 Kda Protein From
Mouse Solved By S-Sad
Length = 559
Score = 30.0 bits (66), Expect = 2.6, Method: Compositional matrix adjust.
Identities = 18/55 (32%), Positives = 28/55 (50%), Gaps = 1/55 (1%)
Query: 329 ILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ 383
+L + D E +E A NK +T LG G + K +LP G ++ V + +S Q
Sbjct: 174 LLLQISGDLEDLEPALNKTNTKPSLGSGSXSALIK-LLPGGHDLLVAHNTWNSYQ 227
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 30.0 bits (66), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFL 104
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 30.0 bits (66), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 18/79 (22%), Positives = 44/79 (55%), Gaps = 2/79 (2%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQE-IAVKRLS-ASSGQGAQEFKNEVVLVAKLQHRNLV 404
F+ +++G+G FGEVYKG+ +E +A+K + + ++ + E+ ++++ +
Sbjct: 21 FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 405 RLLGFCLEGEEKILVYEFV 423
R G L+ + ++ E++
Sbjct: 81 RYFGSYLKSTKLWIIMEYL 99
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 30.0 bits (66), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 30.0 bits (66), Expect = 2.7, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGGELFDFL 104
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 30.0 bits (66), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 30.0 bits (66), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
E+ + +F+ K + G G+ Y + + I +RLS+S G +E + EV ++ +++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEY-----AAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + +L+ E V L FL
Sbjct: 67 HPNIITLHDIFENKTDVVLILELVSGGELFDFL 99
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 29.6 bits (65), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 29.6 bits (65), Expect = 3.0, Method: Compositional matrix adjust.
Identities = 24/93 (25%), Positives = 46/93 (49%), Gaps = 6/93 (6%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
E+ + +F+ K + G G+ Y + + I +RLS+S G +E + EV ++ +++
Sbjct: 19 ELGSGQFAIVRKCRQKGTGKEY-----AAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + +L+ E V L FL
Sbjct: 74 HPNIITLHDIFENKTDVVLILELVSGGELFDFL 106
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 29.6 bits (65), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 350 DNKLGEGGFGEVYKG-----VLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + + + + A+ E E ++ +L + +V
Sbjct: 32 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
R++G C E E +LV E L+ +L
Sbjct: 92 RMIGIC-EAESWMLVMEMAELGPLNKYL 118
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 29.6 bits (65), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 350 DNKLGEGGFGEVYKG-----VLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + + + + A+ E E ++ +L + +V
Sbjct: 32 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
R++G C E E +LV E L+ +L
Sbjct: 92 RMIGIC-EAESWMLVMEMAELGPLNKYL 118
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 29.6 bits (65), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 29.6 bits (65), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 29.6 bits (65), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 21/65 (32%), Positives = 34/65 (52%), Gaps = 8/65 (12%)
Query: 347 FSTDNKLGEGGFGEVYKGVLP----SGQEIAVKRLSASSGQGAQE-FKNEVVLVAKLQHR 401
F LG G F EV VL +G+ AVK + + +G + +NE+ ++ K++H
Sbjct: 24 FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 402 NLVRL 406
N+V L
Sbjct: 81 NIVAL 85
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 29.6 bits (65), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 29.6 bits (65), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 350 DNKLGEGGFGEVYKG-----VLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + + + + A+ E E ++ +L + +V
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
R++G C E E +LV E L+ +L
Sbjct: 434 RMIGIC-EAESWMLVMEMAELGPLNKYL 460
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 29.6 bits (65), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 29.6 bits (65), Expect = 3.7, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 39/88 (44%), Gaps = 6/88 (6%)
Query: 350 DNKLGEGGFGEVYKGVLP-----SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + + + A+ E E ++ +L + +V
Sbjct: 16 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
R++G C E E +LV E L+ +L
Sbjct: 76 RMIGIC-EAESWMLVMEMAELGPLNKYL 102
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 29.6 bits (65), Expect = 3.8, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 39/88 (44%), Gaps = 6/88 (6%)
Query: 350 DNKLGEGGFGEVYKGVLP-----SGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + + + A+ E E ++ +L + +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
R++G C E E +LV E L+ +L
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYL 98
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 29.6 bits (65), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 350 DNKLGEGGFGEVYKG-----VLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + + + + A+ E E ++ +L + +V
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
R++G C E E +LV E L+ +L
Sbjct: 435 RMIGIC-EAESWMLVMEMAELGPLNKYL 461
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 29.6 bits (65), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 350 DNKLGEGGFGEVYKG-----VLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + + + + A+ E E ++ +L + +V
Sbjct: 30 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
R++G C E E +LV E L+ +L
Sbjct: 90 RMIGIC-EAESWMLVMEMAELGPLNKYL 116
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 29.3 bits (64), Expect = 3.9, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 13 YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL 105
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 29.3 bits (64), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 350 DNKLGEGGFGEVYKG-----VLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + + + + A+ E E ++ +L + +V
Sbjct: 10 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
R++G C E E +LV E L+ +L
Sbjct: 70 RMIGIC-EAESWMLVMEMAELGPLNKYL 96
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 29.3 bits (64), Expect = 4.0, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 350 DNKLGEGGFGEVYKG-----VLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + + + + A+ E E ++ +L + +V
Sbjct: 16 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
R++G C E E +LV E L+ +L
Sbjct: 76 RMIGIC-EAESWMLVMEMAELGPLNKYL 102
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 29.3 bits (64), Expect = 4.1, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 3/88 (3%)
Query: 344 TNKFSTDNKLGEGGFGEVYKGVLPSG-QEIAVKRLSAS--SGQGAQEFKNEVVLVAKLQH 400
T+ + +LG+G F V + V + QE A K ++ S + Q+ + E + L+H
Sbjct: 30 TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 401 RNLVRLLGFCLEGEEKILVYEFVPNKSL 428
N+VRL E LV++ V L
Sbjct: 90 PNIVRLHDSISEEGFHYLVFDLVTGGEL 117
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 29.3 bits (64), Expect = 4.3, Method: Compositional matrix adjust.
Identities = 18/77 (23%), Positives = 39/77 (50%), Gaps = 1/77 (1%)
Query: 353 LGEGGFGEVYKGVL-PSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRLLGFCL 411
LG+G FG+ K +G+ + +K L + + F EV ++ L+H N+++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 412 EGEEKILVYEFVPNKSL 428
+ + + E++ +L
Sbjct: 78 KDKRLNFITEYIKGGTL 94
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 29.3 bits (64), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 24/88 (27%), Positives = 40/88 (45%), Gaps = 6/88 (6%)
Query: 350 DNKLGEGGFGEVYKG-----VLPSGQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLV 404
D +LG G FG V KG + + + + A+ E E ++ +L + +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
R++G C E E +LV E L+ +L
Sbjct: 82 RMIGIC-EAESWMLVMEMAELGPLNKYL 108
>pdb|3FGW|A Chain A, One Chain Form Of The 66.3 Kda Protein
Length = 559
Score = 29.3 bits (64), Expect = 4.5, Method: Compositional matrix adjust.
Identities = 18/55 (32%), Positives = 28/55 (50%), Gaps = 1/55 (1%)
Query: 329 ILESLQFDFETIEVATNKFSTDNKLGEGGFGEVYKGVLPSGQEIAVKRLSASSGQ 383
+L + D E +E A NK +T LG G + K +LP G ++ V + +S Q
Sbjct: 174 LLLQISGDLEDLEPALNKTNTKPSLGSGSCSALIK-LLPGGHDLLVAHNTWNSYQ 227
>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
pdb|4F9A|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
pdb|4F9A|C Chain C, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide
pdb|4F9B|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Pha767491
pdb|4F9B|C Chain C, Human Cdc7 Kinase In Complex With Dbf4 And Pha767491
pdb|4F9C|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Xl413
Length = 361
Score = 29.3 bits (64), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 18/49 (36%), Positives = 26/49 (53%), Gaps = 4/49 (8%)
Query: 337 FETIEVATNKFSTDNKLGEGGFGEVYKGV--LPSGQE--IAVKRLSASS 381
+E + +N F ++K+GEG F VY L G E IA+K L +S
Sbjct: 13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS 61
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 29.3 bits (64), Expect = 5.1, Method: Compositional matrix adjust.
Identities = 15/55 (27%), Positives = 30/55 (54%), Gaps = 1/55 (1%)
Query: 353 LGEGGFGEVYKGVLPS-GQEIAVKRLSASSGQGAQEFKNEVVLVAKLQHRNLVRL 406
LG GG G V+ V + +A+K++ + Q + E+ ++ +L H N+V++
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV 73
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 28.9 bits (63), Expect = 5.5, Method: Compositional matrix adjust.
Identities = 25/93 (26%), Positives = 43/93 (46%), Gaps = 7/93 (7%)
Query: 347 FSTDNKLGEGGFGEVYK------GVLPSGQEIAVKRLSASS-GQGAQEFKNEVVLVAKLQ 399
+ T +LG G F V K G+ + + I +R +S G ++ + EV ++ ++Q
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 400 HRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
H N++ L + IL+ E V L FL
Sbjct: 73 HPNVITLHEVYENKTDVILIGELVAGGELFDFL 105
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 28.5 bits (62), Expect = 7.2, Method: Compositional matrix adjust.
Identities = 17/79 (21%), Positives = 44/79 (55%), Gaps = 2/79 (2%)
Query: 347 FSTDNKLGEGGFGEVYKGVLPSGQE-IAVKRLS-ASSGQGAQEFKNEVVLVAKLQHRNLV 404
F+ ++G+G FGEV+KG+ Q+ +A+K + + ++ + E+ ++++ +
Sbjct: 25 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 405 RLLGFCLEGEEKILVYEFV 423
+ G L+G + ++ E++
Sbjct: 85 KYYGSYLKGSKLWIIMEYL 103
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 28.5 bits (62), Expect = 8.3, Method: Compositional matrix adjust.
Identities = 21/88 (23%), Positives = 41/88 (46%), Gaps = 12/88 (13%)
Query: 353 LGEGGFGEV-----YKGVLPSGQEIAVKRLS---ASSGQGAQEFKNEVVLVAKLQHRNLV 404
LGEG FG+V YK + Q++A+K +S + E+ + L+H +++
Sbjct: 17 LGEGSFGKVKLATHYK----TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHII 72
Query: 405 RLLGFCLEGEEKILVYEFVPNKSLDYFL 432
+L + ++V E+ + DY +
Sbjct: 73 KLYDVITTPTDIVMVIEYAGGELFDYIV 100
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 28.1 bits (61), Expect = 9.2, Method: Compositional matrix adjust.
Identities = 22/98 (22%), Positives = 47/98 (47%), Gaps = 8/98 (8%)
Query: 341 EVATNKFSTDNKLGEGGFGEVYKG---VLPSGQEIAVKRL---SASSGQGAQEFKNEVVL 394
++ ++ +KLG GG VY +L ++A+K + + + F+ EV
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 395 VAKLQHRNLVRLLGFCLEGEEKILVYEFVPNKSLDYFL 432
++L H+N+V ++ E + LV E++ +L ++
Sbjct: 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI 102
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 28.1 bits (61), Expect = 9.3, Method: Compositional matrix adjust.
Identities = 18/62 (29%), Positives = 31/62 (50%), Gaps = 2/62 (3%)
Query: 347 FSTDNKLGEGGFGEVY-KGVLPSGQEIAVKRLSASSGQGAQE-FKNEVVLVAKLQHRNLV 404
F KLG G FG+V+ SG E +K ++ Q E + E+ ++ L H N++
Sbjct: 24 FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 405 RL 406
++
Sbjct: 84 KI 85
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 28.1 bits (61), Expect = 10.0, Method: Compositional matrix adjust.
Identities = 10/19 (52%), Positives = 15/19 (78%)
Query: 347 FSTDNKLGEGGFGEVYKGV 365
F+ K+G+G FGEV+KG+
Sbjct: 9 FTKLEKIGKGSFGEVFKGI 27
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.134 0.402
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 11,212,006
Number of Sequences: 62578
Number of extensions: 421871
Number of successful extensions: 1823
Number of sequences better than 100.0: 673
Number of HSP's better than 100.0 without gapping: 232
Number of HSP's successfully gapped in prelim test: 441
Number of HSP's that attempted gapping in prelim test: 1291
Number of HSP's gapped (non-prelim): 676
length of query: 434
length of database: 14,973,337
effective HSP length: 102
effective length of query: 332
effective length of database: 8,590,381
effective search space: 2852006492
effective search space used: 2852006492
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 53 (25.0 bits)